ONEMAIN FINANCE CORP, 10-Q filed on 5/1/2026
Quarterly Report
v3.26.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2026
Apr. 21, 2026
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-36129  
Entity Registrant Name ONEMAIN HOLDINGS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 27-3379612  
Entity Address, Address Line One 601 N.W. Second Street  
Entity Address, City or Town Evansville  
Entity Address, State or Province IN  
Entity Address, Postal Zip Code 47708  
City Area Code 812  
Local Phone Number 424-8031  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol OMF  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   115,530,952
Entity Central Index Key 0001584207  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
OMFC    
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-06155  
Entity Registrant Name ONEMAIN FINANCE CORPORATION  
Entity Incorporation, State or Country Code IN  
Entity Tax Identification Number 35-0416090  
Entity Address, Address Line One 601 N.W. Second Street  
Entity Address, City or Town Evansville  
Entity Address, State or Province IN  
Entity Address, Postal Zip Code 47708  
City Area Code 812  
Local Phone Number 424-8031  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,160,021
Entity Central Index Key 0000025598  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 834 $ 914
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.6 billion in 2026, respectively, and $1.5 billion and $1.6 billion in 2025, respectively) 1,614 1,590
Net finance receivables (includes loans of consolidated VIEs of $13.5 billion in 2026 and $13.4 billion in 2025) 24,447 24,833
Unearned insurance premium and claim reserves (771) (791)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.5 billion in 2026 and $1.6 billion in 2025) (2,819) (2,865)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 20,857 21,177
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $717 million in 2026 and $690 million in 2025) 728 699
Goodwill 1,474 1,474
Other intangible assets 281 282
Other assets 1,230 1,252
Total assets 27,018 27,388
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $11.6 billion in 2026 and $11.5 billion in 2025) 22,396 22,694
Insurance claims and policyholder liabilities 566 576
Deferred and accrued taxes 55 35
Other liabilities (includes other liabilities of consolidated VIEs of $29 million in 2026 and $30 million in 2025) 624 682
Total liabilities 23,641 23,987
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.01 per share; 2,000,000,000 shares authorized, 115,627,261 and 117,196,792 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 1,750 1,757
Accumulated other comprehensive loss (53) (41)
Retained earnings 2,680 2,579
Treasury stock, at cost; 20,397,289 and 18,514,904 shares at March 31, 2026 and December 31, 2025, respectively (1,001) (895)
Total shareholders’ equity 3,377 3,401
Total liabilities and shareholders’ equity $ 27,018 $ 27,388
v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Investment securities, fair value $ 1,555 $ 1,532
Investment securities, amortized cost basis 1,621 1,584
Net finance receivables 24,447 24,833
Financing receivable, allowance for credit loss 2,819 2,865
Restricted cash and restricted cash equivalents 728 699
Long-term debt 22,396 22,694
Other liabilities $ 624 $ 682
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 115,627,261 117,196,792
Common stock, shares outstanding (in shares) 115,627,261 117,196,792
Treasury stock at cost (in shares) 20,397,289 18,514,904
Consolidated VIEs    
Net finance receivables $ 13,526 $ 13,418
Financing receivable, allowance for credit loss 1,536 1,558
Restricted cash and restricted cash equivalents 717 690
Long-term debt 11,586 11,464
Other liabilities $ 29 $ 30
v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Interest income $ 1,387 $ 1,308
Interest expense 322 312
Net interest income 1,065 996
Provision for finance receivable losses 465 456
Net interest income after provision for finance receivable losses 600 540
Other revenues:    
Insurance 112 110
Investment 23 26
Gain on sales of finance receivables 16 16
Net loss on repurchases and repayments of debt (3) (5)
Other 49 41
Total other revenues 197 188
Other expenses:    
Salaries and benefits 240 218
Other operating expenses 209 186
Insurance policy benefits and claims 52 49
Total other expenses 501 453
Income before income taxes 296 275
Income taxes 70 62
Net income $ 226 $ 213
Weighted average number of shares outstanding:    
Basic (in shares) 116,724,709 119,399,008
Diluted (in shares) 117,272,604 119,969,713
Earnings per share:    
Basic (in dollars per share) $ 1.93 $ 1.79
Diluted (in dollars per share) $ 1.93 $ 1.78
v3.26.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net income $ 226 $ 213
Other comprehensive income (loss):    
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities (15) 21
Foreign currency translation adjustments (2) 0
Changes in discount rate for insurance claims and policyholder liabilities 3 1
Other (1) (1)
Income tax effect:    
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities 3 (5)
Foreign currency translation adjustments 1 0
Changes in discount rate for insurance claims and policyholder liabilities (1) 0
Other comprehensive income (loss), net of tax (12) 16
Comprehensive income $ 214 $ 229
v3.26.1
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Beginning balance at Dec. 31, 2024 $ 3,191 $ 1 $ 1,734 $ (81) $ 2,296 $ (759)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (16)         (16)
Treasury stock issued 1         1
Share-based compensation expense, net of forfeitures 10   10      
Withholding tax on share-based compensation (10)   (10)      
Other comprehensive income 16     16    
Cash dividends [1] (125)       (125)  
Net income 213       213  
Ending balance at Mar. 31, 2025 3,280 1 1,734 (65) 2,384 (774)
Beginning balance at Dec. 31, 2025 3,401 1 1,757 (41) 2,579 (895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (107)         (107)
Treasury stock issued 1         1
Share-based compensation expense, net of forfeitures 11   11      
Withholding tax on share-based compensation (18)   (18)      
Other comprehensive income (12)     (12)    
Cash dividends [1] (125)       (125)  
Net income 226       226  
Ending balance at Mar. 31, 2026 $ 3,377 $ 1 $ 1,750 $ (53) $ 2,680 $ (1,001)
[1]
* Cash dividends declared were $1.05 per share and $1.04 per share during the three months ended March 31, 2026 and 2025, respectively.
v3.26.1
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Stockholders' Equity [Abstract]    
Dividends declared (in dollars per share) $ 1.05 $ 1.04
v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ 226 $ 213
Reconciling adjustments:    
Provision for finance receivable losses 465 456
Depreciation and amortization 74 70
Deferred income tax charge 29 15
Net loss on repurchases and repayments of debt 3 5
Share-based compensation expense, net of forfeitures 11 10
Gain on sales of finance receivables (16) (16)
Other (3) (1)
Cash flows due to changes in other assets and other liabilities (50) (87)
Net cash provided by operating activities 739 665
Cash flows from investing activities    
Net principal originations and purchases of finance receivables (526) (552)
Proceeds from sales of finance receivables 362 274
Available-for-sale securities purchased (115) (109)
Available-for-sale securities called, sold, and matured 74 74
Other securities purchased (3) (2)
Other securities called, sold, and matured 4 5
Other, net (23) (21)
Net cash used for investing activities (227) (331)
Cash flows from financing activities    
Proceeds from issuance and borrowings of long-term debt, net of issuance costs 1,101 1,485
Repayments and repurchases of long-term debt (1,412) (1,447)
Cash dividends (128) (126)
Common stock repurchased (107) (16)
Treasury stock issued 1 1
Withholding tax on share-based compensation (18) (10)
Net cash used for financing activities (563) (113)
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents (51) 221
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period 1,613 1,142
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period 1,562 1,363
Supplemental cash flow information    
Cash and cash equivalents 834 627
Restricted cash and restricted cash equivalents 728 736
Total cash and cash equivalents and restricted cash and restricted cash equivalents $ 1,562 $ 1,363
v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - OMFC - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 834 $ 914
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.6 billion in 2026, respectively, and $1.5 billion and $1.6 billion in 2025, respectively) 1,614 1,590
Net finance receivables (includes loans of consolidated VIEs of $13.5 billion in 2026 and $13.4 billion in 2025) 24,447 24,833
Unearned insurance premium and claim reserves (771) (791)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.5 billion in 2026 and $1.6 billion in 2025) (2,819) (2,865)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 20,857 21,177
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $717 million in 2026 and $690 million in 2025) 728 699
Goodwill 1,474 1,474
Other intangible assets 281 282
Other assets 1,230 1,252
Total assets 27,018 27,388
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $11.6 billion in 2026 and $11.5 billion in 2025) 22,396 22,694
Insurance claims and policyholder liabilities 566 576
Deferred and accrued taxes 55 35
Other liabilities (includes other liabilities of consolidated VIEs of $29 million in 2026 and $30 million in 2025) 624 682
Total liabilities 23,641 23,987
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at March 31, 2026 and December 31, 2025 1 1
Additional paid-in capital 1,750 1,757
Accumulated other comprehensive loss (53) (41)
Retained earnings 2,680 2,579
Total shareholders’ equity 3,377 3,401
Total liabilities and shareholders’ equity 27,018 27,388
OMFC    
Assets    
Cash and cash equivalents 793 898
Investment securities (includes available-for-sale securities with a fair value and an amortized cost basis of $1.6 billion and $1.6 billion in 2026, respectively, and $1.5 billion and $1.6 billion in 2025, respectively) 1,614 1,590
Net finance receivables (includes loans of consolidated VIEs of $13.5 billion in 2026 and $13.4 billion in 2025) 24,447 24,833
Unearned insurance premium and claim reserves (771) (791)
Allowance for finance receivable losses (includes allowance of consolidated VIEs of $1.5 billion in 2026 and $1.6 billion in 2025) (2,819) (2,865)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance receivable losses 20,857 21,177
Restricted cash and restricted cash equivalents (includes restricted cash and restricted cash equivalents of consolidated VIEs of $717 million in 2026 and $690 million in 2025) 728 699
Goodwill 1,474 1,474
Other intangible assets 281 282
Other assets 1,230 1,252
Total assets 26,977 27,372
Liabilities and Shareholders’ Equity    
Long-term debt (includes debt of consolidated VIEs of $11.6 billion in 2026 and $11.5 billion in 2025) 22,396 22,694
Insurance claims and policyholder liabilities 566 576
Deferred and accrued taxes 56 36
Other liabilities (includes other liabilities of consolidated VIEs of $29 million in 2026 and $30 million in 2025) 621 682
Total liabilities 23,639 23,988
Contingencies (Note 12)
Shareholders’ equity:    
Common stock, par value $0.50 per share; 25,000,000 shares authorized, 10,160,021 shares issued and outstanding at March 31, 2026 and December 31, 2025 5 5
Additional paid-in capital 1,994 2,001
Accumulated other comprehensive loss (53) (41)
Retained earnings 1,392 1,419
Total shareholders’ equity 3,338 3,384
Total liabilities and shareholders’ equity $ 26,977 $ 27,372
v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - OMFC - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Investment securities, fair value $ 1,555 $ 1,532
Investment securities, amortized cost basis 1,621 1,584
Net finance receivables 24,447 24,833
Financing receivable, allowance for credit loss 2,819 2,865
Restricted cash and restricted cash equivalents 728 699
Long-term debt 22,396 22,694
Other liabilities $ 624 $ 682
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 115,627,261 117,196,792
Common stock, shares outstanding (in shares) 115,627,261 117,196,792
OMFC    
Investment securities, fair value $ 1,600 $ 1,500
Investment securities, amortized cost basis 1,600 1,600
Net finance receivables 24,447 24,833
Financing receivable, allowance for credit loss 2,819 2,865
Restricted cash and restricted cash equivalents 728 699
Long-term debt 22,396 22,694
Other liabilities $ 621 $ 682
Common stock, par value (in dollars per share) $ 0.50 $ 0.50
Common stock, shares authorized (in shares) 25,000,000 25,000,000
Common stock, shares issued (in shares) 10,160,021 10,160,021
Common stock, shares outstanding (in shares) 10,160,021 10,160,021
Consolidated VIEs    
Net finance receivables $ 13,526 $ 13,418
Financing receivable, allowance for credit loss 1,536 1,558
Restricted cash and restricted cash equivalents 717 690
Long-term debt 11,586 11,464
Other liabilities 29 30
Consolidated VIEs | OMFC    
Net finance receivables 13,500 13,400
Financing receivable, allowance for credit loss 1,500 1,600
Restricted cash and restricted cash equivalents 717 690
Long-term debt 11,600 11,500
Other liabilities $ 29 $ 30
v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - OMFC - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Interest income $ 1,387 $ 1,308
Interest expense 322 312
Net interest income 1,065 996
Provision for finance receivable losses 465 456
Net interest income after provision for finance receivable losses 600 540
Other revenues:    
Insurance 112 110
Investment 23 26
Gain on sales of finance receivables 16 16
Net loss on repurchases and repayments of debt (3) (5)
Other 49 41
Total other revenues 197 188
Other expenses:    
Salaries and benefits 240 218
Other operating expenses 209 186
Insurance policy benefits and claims 52 49
Total other expenses 501 453
Income before income taxes 296 275
Income taxes 70 62
Net income 226 213
OMFC    
Interest income 1,387 1,308
Interest expense 322 312
Net interest income 1,065 996
Provision for finance receivable losses 465 456
Net interest income after provision for finance receivable losses 600 540
Other revenues:    
Insurance 112 110
Investment 23 26
Gain on sales of finance receivables 16 16
Net loss on repurchases and repayments of debt (3) (5)
Other 49 41
Total other revenues 197 188
Other expenses:    
Salaries and benefits 240 218
Other operating expenses 209 186
Insurance policy benefits and claims 52 49
Total other expenses 501 453
Income before income taxes 296 275
Income taxes 70 62
Net income $ 226 $ 213
v3.26.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - OMFC - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Net income $ 226 $ 213
Other comprehensive income (loss):    
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities (15) 21
Foreign currency translation adjustments (2) 0
Changes in discount rate for insurance claims and policyholder liabilities 3 1
Other (1) (1)
Income tax effect:    
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities 3 (5)
Foreign currency translation adjustments 1 0
Changes in discount rate for insurance claims and policyholder liabilities (1) 0
Other comprehensive income (loss), net of tax (12) 16
Comprehensive income 214 229
OMFC    
Net income 226 213
Other comprehensive income (loss):    
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities (15) 21
Foreign currency translation adjustments (2) 0
Changes in discount rate for insurance claims and policyholder liabilities 3 1
Other (1) (1)
Income tax effect:    
Net change in unrealized gains (losses) on non-credit impaired available-for-sale securities 3 (5)
Foreign currency translation adjustments 1 0
Changes in discount rate for insurance claims and policyholder liabilities (1) 0
Other comprehensive income (loss), net of tax (12) 16
Comprehensive income $ 214 $ 229
v3.26.1
Condensed Consolidated Statements of Shareholder’s Equity (Unaudited) - OMFC - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
OMFC
OMFC
Common Stock
OMFC
Additional Paid-in Capital
OMFC
Accumulated Other Comprehensive Income (Loss)
OMFC
Retained Earnings
Beginning balance at Dec. 31, 2024 $ 3,191 $ 1 $ 1,734 $ (81) $ 2,296 $ 3,155 $ 5 $ 1,978 $ (81) $ 1,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation expense, net of forfeitures 10   10     10   10    
Withholding tax on share-based compensation (10)   (10)     (10)   (10)    
Other comprehensive income 16     16   16     16  
Cash dividends (125) [1]       (125) [1] (123)       (123)
Net income 213       213 213       213
Ending balance at Mar. 31, 2025 3,280 1 1,734 (65) 2,384 3,261 5 1,978 (65) 1,343
Beginning balance at Dec. 31, 2025 3,401 1 1,757 (41) 2,579 3,384 5 2,001 (41) 1,419
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation expense, net of forfeitures 11   11     11   11    
Withholding tax on share-based compensation (18)   (18)     (18)   (18)    
Other comprehensive income (12)     (12)   (12)     (12)  
Cash dividends (125) [1]       (125) [1] (253)       (253)
Net income 226       226 226       226
Ending balance at Mar. 31, 2026 $ 3,377 $ 1 $ 1,750 $ (53) $ 2,680 $ 3,338 $ 5 $ 1,994 $ (53) $ 1,392
[1]
* Cash dividends declared were $1.05 per share and $1.04 per share during the three months ended March 31, 2026 and 2025, respectively.
v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - OMFC - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ 226 $ 213
Reconciling adjustments:    
Provision for finance receivable losses 465 456
Depreciation and amortization 74 70
Deferred income tax charge 29 15
Net loss on repurchases and repayments of debt 3 5
Share-based compensation expense, net of forfeitures 11 10
Gain on sales of finance receivables (16) (16)
Other (3) (1)
Cash flows due to changes in other assets and other liabilities (50) (87)
Net cash provided by operating activities 739 665
Cash flows from investing activities    
Net principal originations and purchases of finance receivables (526) (552)
Proceeds from sales of finance receivables 362 274
Available-for-sale securities purchased (115) (109)
Available-for-sale securities called, sold, and matured 74 74
Other securities purchased (3) (2)
Other securities called, sold, and matured 4 5
Other, net (23) (21)
Net cash used for investing activities (227) (331)
Cash flows from financing activities    
Proceeds from issuance and borrowings of long-term debt, net of issuance costs 1,101 1,485
Repayments and repurchases of long-term debt (1,412) (1,447)
Cash dividends (128) (126)
Withholding tax on share-based compensation (18) (10)
Net cash used for financing activities (563) (113)
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents (51) 221
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period 1,613 1,142
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period 1,562 1,363
Supplemental cash flow information    
Cash and cash equivalents 834 627
Restricted cash and restricted cash equivalents 728 736
Total cash and cash equivalents and restricted cash and restricted cash equivalents 1,562 1,363
OMFC    
Cash flows from operating activities    
Net income 226 213
Reconciling adjustments:    
Provision for finance receivable losses 465 456
Depreciation and amortization 74 70
Deferred income tax charge 29 15
Net loss on repurchases and repayments of debt 3 5
Share-based compensation expense, net of forfeitures 11 10
Gain on sales of finance receivables (16) (16)
Other (3) (1)
Cash flows due to changes in other assets and other liabilities (53) (89)
Net cash provided by operating activities 736 663
Cash flows from investing activities    
Net principal originations and purchases of finance receivables (526) (552)
Proceeds from sales of finance receivables 362 274
Available-for-sale securities purchased (115) (109)
Available-for-sale securities called, sold, and matured 74 74
Other securities purchased (3) (2)
Other securities called, sold, and matured 4 5
Other, net (23) (21)
Net cash used for investing activities (227) (331)
Cash flows from financing activities    
Proceeds from issuance and borrowings of long-term debt, net of issuance costs 1,101 1,485
Repayments and repurchases of long-term debt (1,412) (1,447)
Cash dividends (256) (124)
Withholding tax on share-based compensation (18) (10)
Net cash used for financing activities (585) (96)
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents (76) 236
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period 1,597 1,108
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period 1,521 1,344
Supplemental cash flow information    
Cash and cash equivalents 793 608
Restricted cash and restricted cash equivalents 728 736
Total cash and cash equivalents and restricted cash and restricted cash equivalents $ 1,521 $ 1,344
v3.26.1
Business and Basis of Presentation
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Basis of Presentation
1. Business and Basis of Presentation

OneMain Holdings, Inc. (“OMH”), and its wholly-owned direct subsidiary, OneMain Finance Corporation (“OMFC”) are financial services holding companies whose subsidiaries engage in the consumer finance and insurance businesses.

The results of OMFC are consolidated into the results of OMH. Due to the nominal differences between OMFC and OMH, content throughout this filing relates to both OMH and OMFC, except where otherwise indicated. OMH and OMFC are referred to in this report, collectively with their subsidiaries, whether directly or indirectly owned, as “the Company,” “OneMain,” “we,” “us,” or “our.”

BASIS OF PRESENTATION

We prepared our condensed consolidated financial statements using generally accepted accounting principles in the United States of America (“GAAP”). These statements are unaudited. The year-end condensed consolidated balance sheet data was derived from our audited financial statements but does not include all disclosures required by GAAP. The statements include the accounts of OMH, its wholly-owned subsidiaries, and variable interest entities (“VIEs”) in which we hold a controlling financial interest and for which we are considered to be the primary beneficiary as of the financial statement date.

We eliminated all material intercompany accounts and transactions. We made judgments, estimates, and assumptions that affect amounts reported in our condensed consolidated financial statements and disclosures of contingent assets and liabilities. In management’s opinion, the condensed consolidated financial statements include the normal, recurring adjustments necessary for a fair statement of results. Actual results could differ from our estimates. We evaluated the effects of and the need to disclose events that occurred subsequent to the balance sheet date.
The condensed consolidated financial statements in this report should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K of OMH and OMFC for the fiscal year ended December 31, 2025, filed with the SEC on February 6, 2026 (“Annual Report”). We follow the same significant accounting policies for our interim reporting.
v3.26.1
Recent Accounting Pronouncements
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Recent Accounting Pronouncements
2. Recent Accounting Pronouncements

ACCOUNTING PRONOUNCEMENTS TO BE ADOPTED

Expense Disaggregation Disclosures

In December of 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires disclosure of certain costs and expenses in the notes to the financial statements. The amendments in this ASU will become effective for fiscal years beginning after December 15, 2026, and will be effective for interim periods with fiscal years beginning after December 15, 2027, with early adoption permitted. The amendments should be applied on a prospective basis, with retrospective application allowed. While the standard will not impact our consolidated financial results, we are currently evaluating the impact of the expanded disclosures.

We do not believe that any other accounting pronouncements issued, but not yet effective, are applicable or would have a material impact on our consolidated financial statements or disclosures, if adopted.
v3.26.1
Finance Receivables
 3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Finance Receivables
3. Finance Receivables

Our finance receivables consist of consumer loans and credit cards. Consumer loans include personal loans and auto finance. Personal loans are non-revolving, with a fixed rate, have fixed terms generally between three and six years, and are secured by automobiles, other collateral, or are unsecured. Auto finance loans are non-revolving, with a fixed rate, have fixed terms generally between three and six years, and are secured by automobiles at the point of purchase through our dealership network. Credit cards are open-ended, revolving, with a fixed rate, and are unsecured.

Components of our net finance receivables were as follows:
Consumer Loans
(dollars in millions)Personal Loans
Auto Finance
Total Consumer Loans
Credit CardsTotal
March 31, 2026
Gross finance receivables *$20,597 $2,514 $23,111 $970 $24,081 
Unearned fees
(252)(41)(293)— (293)
Accrued finance charges and fees358 27 385 — 385 
Deferred origination costs215 46 261 13 274 
Total$20,918 $2,546 $23,464 $983 $24,447 
December 31, 2025
Gross finance receivables *$21,086 $2,438 $23,524 $925 $24,449 
Unearned fees
(258)(42)(300)— (300)
Accrued finance charges and fees382 28 410 — 410 
Deferred origination costs220 43 263 11 274 
Total$21,430 $2,467 $23,897 $936 $24,833 
* Consumer loan gross finance receivables equal the unpaid principal balance net of unamortized discount or premium. For precompute personal loans, unpaid principal balance is the gross contractual payments less the unaccreted balance of unearned finance charges. Credit card gross finance receivables equal the unpaid principal balance, interest, and fees.

WHOLE LOAN SALE TRANSACTIONS

We have whole loan sale flow agreements with third parties. The Company is committed to sell a remaining total of $2.1 billion gross receivables of newly originated unsecured personal loans along with any associated accrued interest with a current term of less than three years. Loans sold are derecognized from our balance sheet at the time of sale. We service the loans sold and are entitled to a servicing fee and other fees commensurate with the services performed as part of the agreements. The gain on sales and servicing fees are recorded in Other revenues in our condensed consolidated statements of operations.

We sold $341 million and $255 million of gross finance receivables during the three months ended March 31, 2026 and 2025, respectively. The gain on the sales were $16 million during both the three months ended March 31, 2026 and 2025.


CREDIT QUALITY INDICATOR

We consider the delinquency status of our finance receivables as our key credit quality indicator. We monitor the delinquency of our finance receivable portfolio, including the migration between the delinquency buckets and changes in the delinquency trends to manage our exposure to credit risk in the portfolio.

When consumer loans are 60 days contractually past due, we consider these accounts to be at an increased risk for loss and move collection of these accounts to our central collection operations. We consider our consumer loans to be nonperforming at 90 days or more contractually past due, at which point we stop accruing finance charges and reverse finance charges previously accrued. All consumer loans in nonaccrual status are considered in our estimate of allowance for finance receivable losses.
The following table below is a summary of finance charges on our consumer loans:
Three Months Ended March 31,
20262025
(dollars in millions)Personal Loans
Auto
Finance
Personal Loans
Auto
Finance
 
Net accrued finance charges reversed
$47 $3 $41 $3 
Finance charges recognized from the contractual interest portion of payments received on nonaccrual loans
6—6—

We accrue finance charges and fees on credit cards until charge-off at 180 days contractually past due, at which point we reverse finance charges and fees previously accrued.

Net accrued finance charges and fees reversed on credit cards were as follows:
Three Months Ended March 31,
(dollars in millions)
20262025
Net accrued finance charges and fees reversed$23 $17 

The following tables below are a summary of our personal loans by the year of origination and number of days delinquent:

(dollars in millions)20262025202420232022PriorTotal
March 31, 2026
Performing
Current$2,472 $8,826 $4,600 $2,321 $1,125 $458 $19,802 
30-59 days past due2 108 91 62 42 27 332 
60-89 days past due— 75 62 40 26 17 220 
Total performing2,474 9,009 4,753 2,423 1,193 502 20,354 
Nonperforming (Nonaccrual)
90+ days past due— 158 174 113 72 47 564 
Total$2,474 $9,167 $4,927 $2,536 $1,265 $549 $20,918 
Gross charge-offs *
$— $105 $179 $125 $73 $41 $523 
* Represents gross charge-offs for the three months ended March 31, 2026.

(dollars in millions)20252024202320222021PriorTotal
December 31, 2025
Performing
Current$10,149 $5,335 $2,759 $1,372 $439 $146 $20,200 
30-59 days past due101 120 85 60 29 12 407 
60-89 days past due63 82 53 36 17 7 258 
Total performing10,313 5,537 2,897 1,468 485 165 20,865 
Nonperforming (Nonaccrual)
90+ days past due99 191 135 86 38 16 565 
Total$10,412 $5,728 $3,032 $1,554 $523 $181 $21,430 
Gross charge-offs *
$— $86 $181 $136 $63 $26 $492 
* Represents gross charge-offs for the three months ended March 31, 2025.
The following tables below are a summary of our auto finance loans by the year of origination and number of days delinquent:

(dollars in millions)20262025202420232022PriorTotal
March 31, 2026
Performing
Current$341 $996 $602 $291 $129 $45 $2,404 
30-59 days past due1 33 27 14 10 5 90 
60-89 days past due— 9 6 3 2 1 21 
Total performing342 1,038 635 308 141 51 2,515 
Nonperforming (Nonaccrual)
90+ days past due— 10 10 6 3 2 31 
Total$342 $1,048 $645 $314 $144 $53 $2,546 
Gross charge-offs *
$— $13 $15 $8 $5 $2 $43 
* Represents gross charge-offs for the three months ended March 31, 2026.

(dollars in millions)20252024202320222021PriorTotal
December 31, 2025
Performing
Current$1,095 $667 $329 $152 $48 $9 $2,300 
30-59 days past due34 34 21 13 6 1 109 
60-89 days past due8 10 5 3 1 — 27 
Total performing1,137 711 355 168 55 10 2,436 
Nonperforming (Nonaccrual)
90+ days past due8 12 6 3 2 — 31 
Total$1,145 $723 $361 $171 $57 $10 $2,467 
Gross charge-offs *
$— $10 $11 $8 $3 $1 $33 
* Represents gross charge-offs for the three months ended March 31, 2025.

The following is a summary of credit cards by number of days delinquent:
(dollars in millions)March 31, 2026December 31, 2025
Current
$868 $820 
30-59 days past due
24 26 
60-89 days past due
23 24 
90+ days past due
68 66 
Total
$983 $936 

There were no credit cards that were converted to term loans at March 31, 2026 or December 31, 2025.

UNFUNDED LENDING COMMITMENTS

Our unfunded lending commitments consist of the unused credit card lines, which are unconditionally cancellable. We do not anticipate that all of our customers will access their entire available line at any given point in time. The unused credit card lines totaled $619 million and $500 million at March 31, 2026 and December 31, 2025, respectively.
MODIFIED FINANCE RECEIVABLES TO BORROWERS EXPERIENCING FINANCIAL DIFFICULTY

We make modifications to our finance receivables to assist borrowers who are experiencing financial difficulty. When we modify the contractual terms for economic or other reasons related to the borrower’s financial difficulties, we classify that receivable as a modified finance receivable.

The period-end carrying value of net finance receivables modified during the period was as follows:
Three Months Ended March 31,
20262025
(dollars in millions)Personal Loans
Auto
 Finance
Personal Loans
Auto
 Finance
 
Interest rate reduction and term extension$106$8$95 $7
Interest rate reduction and principal forgiveness881119 —
Total modifications to borrowers experiencing financial difficulties$194$9$214 $7
Modifications as a percent of net finance receivables by class
0.93 %0.34 %1.04 %0.33 %

The financial effect of modifications made during the period was as follows:
Three Months Ended March 31,
20262025
(dollars in millions)Personal Loans
Auto
Finance
Personal Loans
Auto
Finance
 
Net finance receivables 
Weighted-average interest rate reduction21.02 %14.50 %16.14 %12.98 %
Weighted-average term extension (months)30192416
Principal/interest forgiveness$9$—$7 $—

The performance of finance receivables modified within the previous 12 months by delinquency status was as follows:
March 31, 2026 (a)March 31, 2025 (b)
(dollars in millions)Personal Loans
Auto
Finance
Personal Loans
Auto
Finance
Current
$523 $20 $515 $15 
30-59 days past due
44 3 51 2 
60-89 days past due32 1 36 1 
90+ days past due
74 2 79 1 
Total
$673 $26 $681 $19 
(a) Excludes $75 million of personal loan receivables that were modified and subsequently charged off within the previous 12 months. Auto finance receivables that were modified and subsequently charged off within the previous 12 months were immaterial.
(b) Excludes $99 million of personal loan receivables that were modified and subsequently charged off. Auto finance receivables that were modified and subsequently charged off were immaterial.
The period-end carrying value of finance receivables that defaulted during the period to cause the receivable to be considered nonperforming (90 days or more contractually past due) and had been modified within the 12 months preceding the default was as follows:
Three Months Ended March 31,
20262025
(dollars in millions)
Personal
Loans
Auto
 Finance
Personal Loans
Auto
 Finance
Interest rate reduction and term extension$35 $2 $31 $1 
Interest rate reduction and principal forgiveness19 — 19 — 
Total
$54 $2 $50 $1 

Modifications made to credit cards were immaterial for the three months ended March 31, 2026 and 2025.
v3.26.1
Allowance for Finance Receivable Losses
 3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Allowance for Finance Receivable Losses
4. Allowance for Finance Receivable Losses

We establish an allowance for finance receivable losses through the provision for finance receivable losses. We evaluate our finance receivable portfolio by the level of contractual delinquency in the portfolio, specifically in the late-stage delinquency buckets and inclusive of the migration of the finance receivables through the delinquency buckets. We estimate and record an allowance for finance receivable losses to cover the expected lifetime credit losses on our finance receivables. Our allowance for finance receivable losses may fluctuate based upon changes in portfolio growth, credit quality, and economic conditions.

Our methodology to estimate expected credit losses uses recent macroeconomic forecasts, which include forecasts for unemployment. We leverage projections from various industry leading providers. We also consider inflationary pressures, consumer confidence levels, and elevated interest rates that may continue to impact the economic outlook. At March 31, 2026, our economic forecast used a reasonable and supportable period of 12 months. The decrease in our allowance for finance receivable losses for the three months ended March 31, 2026 was driven by a seasonal decline in net finance receivables. We may experience further changes to the macroeconomic assumptions within our forecast, as well as changes to our loan loss performance outlook, both of which could lead to further changes in our allowance for finance receivable losses, allowance ratio, and provision for finance receivable losses.

Changes in the allowance for finance receivable losses were as follows:
(dollars in millions)
Consumer Loans
Credit CardsTotal
Three Months Ended March 31, 2026  
Balance at beginning of period$2,656 $209 $2,865 
Provision for finance receivable losses419 46 465 
Charge-offs(566)(49)(615)
Recoveries98 6 104 
Balance at end of period$2,607 $212 $2,819 
Three Months Ended March 31, 2025  
Balance at beginning of period$2,567 $138 $2,705 
Provision for finance receivable losses
409 47 456 
Charge-offs(525)(36)(561)
Recoveries85 3 88 
Balance at end of period$2,536 $152 $2,688 
v3.26.1
Investment Securities
 3 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Investment Securities
5. Investment Securities

AVAILABLE-FOR-SALE SECURITIES

Cost/amortized cost, allowance for credit losses, unrealized gains and losses, and fair value of fixed maturity available-for-sale securities by type were as follows:
(dollars in millions)Cost/
Amortized
Cost		Unrealized
Gains		Unrealized
Losses		Fair
Value
March 31, 2026*    
Fixed maturity available-for-sale securities:    
U.S. government and government sponsored entities$13 $— $— $13 
Obligations of states, municipalities, and political subdivisions
58 — (3)55 
Commercial paper
13 — — 13 
Non-U.S. government and government sponsored entities
150 1 (3)148 
Corporate debt
1,088 6 (47)1,047 
Mortgage-backed, asset-backed, and collateralized:
   
RMBS
207 1 (17)191 
CMBS
20 — (2)18 
CDO/ABS
72 — (2)70 
Total$1,621 $8 $(74)$1,555 
December 31, 2025*
Fixed maturity available-for-sale securities:
U.S. government and government sponsored entities
$13 $— $— $13 
 Obligations of states, municipalities, and political subdivisions
59 — (3)56 
Commercial paper— — — — 
Non-U.S. government and government sponsored entities159 1 (3)157 
Corporate debt1,057 11 (38)1,030 
Mortgage-backed, asset-backed, and collateralized:
RMBS206 1 (17)190 
CMBS24 — (2)22 
CDO/ABS66 — (2)64 
Total$1,584 $13 $(65)$1,532 
*    The allowance for credit losses related to our investment securities as of March 31, 2026 and December 31, 2025 was immaterial.

Interest receivables reported in Other assets in our condensed consolidated balance sheets totaled $14 million as of March 31, 2026 and December 31, 2025. There were no material amounts reversed from investment revenue for available-for-sale securities for the three months ended March 31, 2026 and 2025.
Fair value and unrealized losses on available-for-sale securities by type and length of time in a continuous unrealized loss position without an allowance for credit losses were as follows:
 Less Than 12 Months12 Months or LongerTotal
(dollars in millions)Fair
Value
Unrealized
Losses
Fair
Value		Unrealized
Losses		Fair
Value		Unrealized
Losses
March 31, 2026      
U.S. government and government sponsored entities
$— $— $8 $— $8 $— 
Obligations of states, municipalities, and political subdivisions
4 — 45 (3)49 (3)
Non-U.S. government and government sponsored entities
50 — 34 (3)84 (3)
Corporate debt279 (4)503 (43)782 (47)
Mortgage-backed, asset-backed, and collateralized:
RMBS27 — 121 (17)148 (17)
CMBS3 — 15 (2)18 (2)
CDO/ABS25 — 23 (2)48 (2)
Total$388 $(4)$749 $(70)$1,137 $(74)
December 31, 2025
      
U.S. government and government sponsored entities
$— $— $8 $— $8 $— 
Obligations of states, municipalities, and political subdivisions
1 — 48 (3)49 (3)
Non-U.S. government and government sponsored entities
23 — 37 (3)60 (3)
Corporate debt73 — 545 (38)618 (38)
Mortgage-backed, asset-backed, and collateralized:
RMBS6 — 124 (17)130 (17)
CMBS1 — 19 (2)20 (2)
CDO/ABS6 — 28 (2)34 (2)
Total$110 $— $809 $(65)$919 $(65)

On a lot basis, we had 1,563 and 1,355 investment securities in an unrealized loss position at March 31, 2026 and December 31, 2025, respectively. We do not consider the unrealized losses to be credit-related, as these unrealized losses primarily relate to changes in interest rates and market spreads subsequent to purchase. Additionally, as of March 31, 2026, there were no credit impairments on investment securities that we intend to sell. We do not have plans to sell any of the remaining investment securities with unrealized losses as of March 31, 2026, and we believe it is more likely than not that we would not be required to sell such investment securities before recovery of their amortized cost.

We continue to monitor unrealized loss positions for potential credit impairments. During the three months ended March 31, 2026 and 2025, there were no material credit impairments related to our investment securities. Therefore, there were no material additions or reductions in the allowance for credit losses (impairments recognized or reversed in earnings) on credit impaired available-for-sale securities for the three months ended March 31, 2026 and 2025.

The proceeds of available-for-sale securities sold or redeemed during the three months ended March 31, 2026 and 2025 totaled $38 million and $22 million, respectively. The net realized gains and losses were immaterial during the three months ended March 31, 2026 and 2025.
Contractual maturities of fixed-maturity available-for-sale securities at March 31, 2026 were as follows:
(dollars in millions)Fair
Value		Amortized
Cost
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities:
  
Due in 1 year or less$152 $152 
Due after 1 year through 5 years606 624 
Due after 5 years through 10 years375 387 
Due after 10 years143 159 
Mortgage-backed, asset-backed, and collateralized securities279 299 
Total$1,555 $1,621 

Actual maturities may differ from contractual maturities since issuers and borrowers may have the right to call or prepay obligations. We may sell investment securities before maturity for general corporate and working capital purposes and to achieve certain investment strategies.

The fair value of securities on deposit with third parties totaled $510 million and $490 million at March 31, 2026 and December 31, 2025, respectively.

OTHER SECURITIES

The fair value of other securities by type was as follows:
(dollars in millions)March 31, 2026December 31, 2025
Fixed maturity other securities: 
Bonds$4 $6 
Preferred stock
12 12 
Common stock
43 40 
Total $59 $58 

Other securities primarily consist of equity securities and those securities for which the fair value option was elected. We report net unrealized and realized gains and losses on other securities held, sold, or redeemed in Other revenue - investment. Net unrealized gains and losses on other securities held were immaterial for the three months ended March 31, 2026 and 2025. Net realized gains and losses on other securities sold or redeemed were immaterial for the three months ended March 31, 2026 and 2025.
v3.26.1
Long-term Debt
 3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Long-term Debt
6. Long-term Debt

Principal maturities of long-term debt by type of debt at March 31, 2026 were as follows:
Senior Debt
(dollars in millions)Securitizations
Private Secured Term Funding
Revolving
Conduit
Facilities		Unsecured
Notes (a)		Junior
Subordinated
Debt (a)		Total
Interest rates (b)
1.55%-10.98%
4.88%
4.80%
3.50%-7.88%
5.68 %
Remainder of 2026$— $— $— $— $— $— 
2027— — — 750 — 750 
2028— — — 1,350 — 1,350 
2029— — — 1,640 — 1,640 
2030— — — 2,292 — 2,292 
2031-2067— — — 4,700 350 5,050 
Secured (c)11,274 350 1 — — 11,625 
Total principal maturities$11,274 $350 $1 $10,732 $350 $22,707 
Total carrying amount$11,236 $349 $1 $10,637 $173 $22,396 
Debt issuance costs (d)(36)(1)— (92)— (129)
(a) Pursuant to the Base Indenture, the Supplemental Indentures, and the Guaranty Agreements, OMH agreed to fully and unconditionally guarantee, on a senior unsecured basis, payments of principal, premium and interest on the Unsecured Notes and Junior Subordinated Debenture. The OMH guarantees of OMFC’s long-term debt are subject to customary release provisions.
(b) The interest rates shown are the range of contractual rates in effect at March 31, 2026.
(c) Securitizations, private secured term funding, and borrowings under the revolving conduit facilities are not included in the above maturities by period due to their variable monthly repayments, which may result in pay-off prior to the stated maturity date. See Note 7 for further information on our long-term debt associated with securitizations, private secured term funding, and revolving conduit facilities.
(d) Debt issuance costs are reported as a direct reduction from long-term debt, with the exception of debt issuance costs associated with our revolving conduit facilities, credit card revolving variable funding note (“VFN”) facilities, and the unsecured corporate revolver, which totaled $34 million at March 31, 2026 and are reported in Other assets in our condensed consolidated balance sheets.


UNSECURED CORPORATE REVOLVER

At March 31, 2026, the total maximum borrowing capacity of our unsecured corporate revolver was $1.1 billion. The corporate revolver has a five-year term, during which draws and repayments may occur. Any outstanding principal balance is due and payable on September 6, 2029.
v3.26.1
Variable Interest Entities
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Variable Interest Entities
7. Variable Interest Entities

CONSOLIDATED VIES

We have transferred finance receivables to VIEs for asset-backed financing transactions and include the assets and liabilities in our condensed consolidated financial statements because we are the primary beneficiary of each VIE. We account for these asset-backed debt obligations as securitized borrowings.

See Note 2 and Note 10 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report for more detail regarding VIEs.

We parenthetically disclose on our condensed consolidated balance sheets the VIEs’ assets that can only be used to settle the VIEs’ obligations and liabilities when their creditors have no recourse against the primary beneficiary’s general credit. The carrying amounts of consolidated VIE assets and liabilities associated with our securitization trusts, private secured term funding, revolving conduit facilities, and credit card revolving VFN facilities were as follows:
(dollars in millions)March 31, 2026December 31, 2025
Assets  
Cash and cash equivalents$5 $5 
Net finance receivables13,526 13,418 
Allowance for finance receivable losses1,536 1,558 
Restricted cash and restricted cash equivalents717 690 
Other assets42 41 
Liabilities  
Long-term debt$11,586 $11,464 
Other liabilities29 30 

Other than the retained subordinate and residual interests in our consolidated VIEs, we are under no further obligation than is otherwise noted herein, either contractually or implicitly, to provide financial support to these entities. Consolidated interest expense related to our VIEs totaled $146 million and $159 million during the three months ended March 31, 2026 and 2025, respectively.

SECURITIZED BORROWINGS

Our outstanding OneMain Financial Issuance Trust (“OMFIT”) and OneMain Direct Auto Receivables Trust (“ODART”) securitizations contain a revolving period ranging from two to seven years during which no principal payments are required to be made on the related asset-backed notes. The indentures governing our OMFIT and ODART securitized borrowings contain early amortization events and events of default, that, if triggered, may result in the acceleration of the obligation to pay principal and interest on the related asset-backed notes. Our Foursight Capital Automobile Receivables Trust ("FCRT") securitizations are amortizing.

CREDIT CARD REVOLVING VFN FACILITIES

We have transferred credit card gross finance receivables to a master trust, OneMain Financial Credit Card Trust (“OMFCT”), and we continue to service and administer the credit cards. As of March 31, 2026, OMFCT was the issuing entity for two credit card revolving VFN facilities by way of certain indenture supplements and note purchase agreements with a total maximum borrowing capacity of $500 million. Each credit card revolving VFN facility has a revolving period during which no principal payments are required, but may be made without penalty, followed by a subsequent amortization period. Principal balances of outstanding notes, if any, are due and payable in full over periods ranging up to four years as of March 31, 2026. Amounts drawn on these credit card revolving VFN facilities are secured and collateralized by our credit card gross finance receivables.
PRIVATE SECURED TERM FUNDING

At March 31, 2026, the maximum borrowing capacity of $350 million was outstanding under a private secured term funding facility. Principal payments on any outstanding balances are not required until after October 2027, followed by a subsequent amortization period, which upon expiration the outstanding principal is due and payable.

REVOLVING CONDUIT FACILITIES
We had access to 17 revolving conduit facilities with a total maximum borrowing capacity of $5.9 billion as of March 31, 2026. Our conduit facilities contain revolving periods during which no principal payments are required, but may be made without penalty, followed by a subsequent amortization period. Principal balances of outstanding loans, if any, are due and payable in full over periods ranging up to approximately nine years as of March 31, 2026. Amounts drawn on these facilities are collateralized by our consumer loans.
v3.26.1
Insurance
 3 Months Ended
Mar. 31, 2026
Insurance [Abstract]  
Insurance
8. Insurance

Changes in the reserve for unpaid claims and loss adjustment expenses (net of reinsurance recoverables) on our short-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
(dollars in millions)20262025
Balance at beginning of period$98 $102 
Less reinsurance recoverables(3)(3)
Net balance at beginning of period95 99 
Additions for losses and loss adjustment expenses incurred to:
Current year53 52 
Prior years *
(2)(6)
Total51 46 
Reductions for losses and loss adjustment expenses paid related to:
Current year(17)(17)
Prior years(34)(32)
Total(51)(49)
Net balance at end of period95 96 
Plus reinsurance recoverables3 2 
Balance at end of period$98 $98 
*    At March 31, 2026, there were redundancies in the prior years’ net reserves due to favorable developments of credit life claims during the period. At March 31, 2025, there were redundancies in the prior years’ net reserves due to favorable developments of credit disability claims during the period.

LIABILITY FOR FUTURE POLICY BENEFITS

The present values of expected net premiums on long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
 Whole Life		Accidental Death and Disability ProtectionTerm and
 Whole Life		Accidental Death and Disability Protection
Balance at beginning of period$138 $28 $177 $33 
Effect of cumulative changes in discount rate assumptions (beginning of period)(3)— (2)— 
Beginning balance at original discount rate135 28 175 33 
Effect of actual variances from expected experience(1)(2)(3)— 
Adjusted balance at beginning of period134 26 172 33 
Interest accretion2 — 2 — 
Net premiums collected(6)(1)(6)(1)
Ending balance at original discount rate130 25 168 32 
Effect of changes in discount rate assumptions1 — 1 (1)
Balance at ending of period$131 $25 $169 $31 
The present values of expected future policy benefits on long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Balance at beginning of period$329 $90 $378 $96 
Effect of cumulative changes in discount rate assumptions (beginning of period)(9)1(5)2
Beginning balance at original discount rate3209137398
Effect of actual variances from expected experience(2)(4)(2)(1)
Adjusted balance at beginning of period3188737197
Net issuances1—1—
Interest accretion4151
Benefit payments(10)(2)(13)(3)
Ending balance at original discount rate3138636495
Effect of changes in discount rate assumptions4(1)3(2)
Balance at ending of period$317 $85 $367 $93 

The net liabilities for future policy benefits on long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Net liability for future policy benefits$186 $60 $198 $62 
Deferred profit liability12431147
Total net liability for future policy benefits$198 $103 $209 $109 

The weighted-average duration of the liability for future policy benefits was 7 years at March 31, 2026 and 8 years at March 31, 2025.

The following table reconciles the net liability for future policy benefits to Insurance claims and policyholder liabilities in the condensed consolidated balance sheets:
At or for the
Three Months Ended March 31,
(dollars in millions)20262025
Term and whole life$198 $209 
Accidental death and disability protection103 109 
Other*265 249 
Total insurance claims and policyholder liabilities
$566 $567 
*    Other primarily includes reserves for short-duration contracts that are payable to third-party beneficiaries.
The undiscounted and discounted expected future gross premiums and expected future benefits and expenses for our long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Expected future gross premiums:
Undiscounted$273 $96 $352 $119 
Discounted206 69 254 85 
Expected future benefit payments:
Undiscounted429 124 514 140 
Discounted317 85 367 93 

The revenue and interest accretion related to our long-duration insurance contracts recognized in the condensed consolidated statements of operations were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Gross premiums or assessments$11 $3 $12 $4 
Interest accretion$2 $1 $3 $1 

The expected and actual experiences for mortality, morbidity, and lapses of the liability for future policy benefits were as follows:
At or for the
Three Months Ended March 31,
20262025
Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Mortality/Morbidity:
Expected0.41 %0.02 %0.39 %0.01 %
Actual0.37 %0.01 %0.41 %0.01 %
Lapses:
Expected3.85 %1.60 %3.79 %1.71 %
Actual4.16 %3.93 %3.00 %2.38 %

The weighted-average interest rates for the liability of future policy benefits for our long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Interest accretion rate5.28 %4.85 %5.29 %4.86 %
Current discount rate5.40 %5.58 %5.40 %5.49 %
v3.26.1
Capital Stock and Earnings Per Share (OMH Only)
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Capital Stock and Earnings Per Share (OMH Only)
9. Capital Stock and Earnings Per Share (OMH Only)

CAPITAL STOCK

OMH has two classes of authorized capital stock: preferred stock and common stock. OMFC has two classes of authorized capital stock: special stock and common stock. OMH and OMFC may issue preferred stock and special stock, respectively, in one or more series. The OMH Board of Directors and the OMFC Board of Directors determine the dividend, liquidation, redemption, conversion, voting, and other rights prior to issuance.

Changes in OMH shares of common stock issued and outstanding were as follows:
Three Months Ended March 31,
20262025
Balance at beginning of period117,196,792 119,360,509 
Common stock issued 312,854 223,914 
Common stock repurchased(1,901,698)(323,176)
Treasury stock issued19,313 20,313 
Balance at end of period115,627,261 119,281,560 


EARNINGS PER SHARE (OMH ONLY)

The computation of earnings per share was as follows:
Three Months Ended March 31,
(dollars in millions, except per share data)20262025
 
Numerator (basic and diluted):  
Net income$226 $213 
Denominator:  
Weighted average number of shares outstanding (basic)116,724,709 119,399,008 
Effect of dilutive securities *547,895 570,705 
Weighted average number of shares outstanding (diluted)117,272,604 119,969,713 
Earnings per share:  
Basic$1.93 $1.79 
Diluted$1.93 $1.78 
* We have excluded weighted-average unvested restricted stock units totaling 494,273 and 777,055 for the three months ended March 31, 2026 and 2025, respectively, from the fully-diluted earnings per share calculations as these shares would be anti-dilutive, which could impact the earnings per share calculation in the future.

Basic earnings per share is computed by dividing net income by the weighted-average number of shares outstanding during each period. Diluted earnings per share is computed based on the weighted-average number of shares outstanding plus the effect of potentially dilutive shares outstanding during the period using the treasury stock method. The potentially dilutive shares represent outstanding unvested restricted stock units.
v3.26.1
Accumulated Other Comprehensive Income (Loss)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
10. Accumulated Other Comprehensive Income (Loss)

Changes, net of tax, in Accumulated other comprehensive income (loss) were as follows:
(dollars in millions)Unrealized
Gains (Losses)
Available-for-Sale Securities (a)		Retirement
Plan Liabilities
Adjustments		Foreign
Currency
Translation
Adjustments
Changes in Discount Rate for Insurance Claims and Policyholder Liabilities
Other (b)Total
Accumulated
Other
Comprehensive
Income (Loss)
Three Months Ended
March 31, 2026		    
Balance at beginning of period$(41)$(2)$(7)$(3)$12 $(41)
Other comprehensive income (loss) before reclassifications
(12)— (1)2 (1)(12)
Balance at end of period$(53)$(2)$(8)$(1)$11 $(53)
Three Months Ended
March 31, 2025		    
Balance at beginning of period$(81)$(3)$(13)$(1)$17 $(81)
Other comprehensive income (loss) before reclassifications
16 — — 1 (1)16 
Balance at end of period$(65)$(3)$(13)$— $16 $(65)
(a) There were no material amounts related to available-for-sale debt securities for which an allowance for credit losses was recorded during the three months ended March 31, 2026 and 2025.
(b) Other primarily includes changes in the fair value of our mark-to-market derivative instruments that have been designated as cash flow hedges.

Reclassification adjustments from Accumulated other comprehensive income (loss) to the applicable line item on our condensed consolidated statements of operations were immaterial for the three months ended March 31, 2026 and 2025.
v3.26.1
Income Taxes
 3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes
11. Income Taxes

We follow the guidance of ASC 740, Income Taxes, for interim reporting of income taxes under which we calculate an estimated annual effective tax rate (“AETR”) and apply the AETR to our year-to-date income (loss) before income taxes. In addition, we recognize any discrete items as they occur.

We had a net deferred tax asset of $438 million and $464 million at March 31, 2026 and December 31, 2025, respectively, reported in Other assets in our condensed consolidated balance sheets.

Our gross unrecognized tax benefits, including related interest and penalties, totaled $17 million and $14 million at March 31, 2026 and December 31, 2025, respectively.
v3.26.1
Contingencies
 3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
12. Contingencies

LEGAL CONTINGENCIES

In the normal course of business, we have been named, from time to time, as defendants in various legal actions, including arbitrations, class actions, and other litigation arising in connection with our activities. Some of the actual or threatened legal actions include claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages. Additionally, we are, from time to time, in the normal course of business, subject to inquiries and investigations by federal, state, and local governmental authorities regarding our products and our operations. These inquiries and investigations may result in fines, restitution, or other penalties, including injunctive relief that may result in restrictions on our business. While we will continue to evaluate legal actions to determine whether a loss is reasonably possible or probable and is reasonably estimable, there can be no assurance that material losses will not be incurred from pending, threatened or future litigation, investigations, examinations, or other claims.

We contest liability and/or the amount of damages, as appropriate, in each pending matter. Where available information indicates that it is probable that a liability had been incurred at the date of the condensed consolidated financial statements and we can reasonably estimate the amount of that loss, we accrue the estimated loss by a charge to income. In many actions, however, it is inherently difficult to determine whether any loss is probable or even reasonably possible, or to estimate the amount of any loss. In addition, even where loss is reasonably possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is not always possible to reasonably estimate the size of the possible loss or range of loss.

For certain legal actions, we cannot reasonably estimate such losses, particularly for actions that are in their early stages of development or where plaintiffs seek substantial or indeterminate damages. Numerous issues may need to be resolved, including through potentially lengthy discovery and determination of important factual matters, and by addressing novel or unsettled legal questions relevant to the actions in question, before a loss or additional loss or range of loss or range of additional loss can be reasonably estimated for any given action.

For certain other legal actions, we can estimate reasonably possible losses, additional losses, ranges of loss or ranges of additional loss in excess of amounts accrued, but do not believe, based on current knowledge and after consultation with counsel, that such losses will have a material adverse effect on our condensed consolidated financial statements as a whole.
v3.26.1
Segment Information
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information
13. Segment Information

At March 31, 2026, Consumer and Insurance (“C&I”) is our only reportable segment. The remaining components (which we refer to as “Other”) consist of our liquidating SpringCastle Portfolio servicing activity and our non-originating legacy operations, which primarily include our liquidating real estate loans.

The accounting policies of the C&I segment are the same as those disclosed in Note 2 and Note 18 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report.

We have identified the following significant segment expenses: Interest expense, Provision for finance receivable losses, Salaries and benefits expense, Other operating expenses, and Insurance policy benefits and claims expense. Based on our identified significant segment expenses, there are no other segment items.

Our chief operating decision maker (“CODM”) is our Chief Executive Officer (“CEO”). The CODM uses Income (loss) before income tax expense (benefit) to assess the performance of the C&I segment, allocate resources, and make strategic operating decisions.

The following tables present information about C&I and Other, as well as reconciliations to the condensed consolidated financial statement amounts.
(dollars in millions)Consumer
and
Insurance		OtherSegment to
GAAP
Adjustment		Consolidated
Total
Three Months Ended March 31, 2026  
Interest income$1,383 $1 $3 $1,387 
Interest expense322 — — 322 
Provision for finance receivable losses
465 — — 465 
Net interest income after provision for finance receivable losses
596 1 3 600 
Other revenues195 2 — 197 
Salaries and benefits
239 1 — 240 
Other operating expenses
207 2 — 209 
Insurance policy benefits and claims
52 — — 52 
Income before income tax expense
$293 $— $3 $296 
Assets$25,869 $6 $1,143 $27,018 
Three Months Ended March 31, 2025
Interest income$1,301 $1 $6 $1,308 
Interest expense311 — 1 312 
Provision for finance receivable losses
456 — — 456 
Net interest income after provision for finance receivable losses
534 1 5 540 
Other revenues186 2 — 188 
Salaries and benefits
217 1 — 218 
Other operating expenses
184 1 1 186 
Insurance policy benefits and claims
49 — — 49 
Income before income tax expense
$270 $1 $4 $275 
Assets$24,889 $11 $1,129 $26,029 
v3.26.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements
14. Fair Value Measurements

The accounting policies of our fair value measurements are the same as those disclosed in Note 2 and Note 19 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report.

The following table presents the carrying amounts and estimated fair values of our financial instruments and indicates the level in the fair value hierarchy of the estimated fair value measurement based on the observability of the inputs used:
Fair Value Measurements UsingTotal
Fair
Value		Total
Carrying
Value
(dollars in millions)Level 1Level 2Level 3
March 31, 2026
Assets
Cash and cash equivalents$819 $15 $— $834 $834 
Investment securities59 1,551 4 1,614 1,614 
Net finance receivables, less allowance for finance receivable losses
— — 24,036 24,036 21,628 
Restricted cash and restricted cash equivalents 728 — — 728 728 
Other assets *
— — 31 31 17 
Liabilities
Long-term debt $— $22,369 $— $22,369 $22,396 
December 31, 2025
Assets
Cash and cash equivalents$860 $54 $— $914 $914 
Investment securities57 1,530 3 1,590 1,590 
Net finance receivables, less allowance for finance receivable losses
— — 24,440 24,440 21,968 
Restricted cash and restricted cash equivalents 699 — — 699 699 
Other assets *
— — 31 31 18 
Liabilities
Long-term debt$— $23,204 $— $23,204 $22,694 
*Other assets at March 31, 2026 and December 31, 2025 primarily consists of finance receivables held for sale.
FAIR VALUE MEASUREMENTS — RECURRING BASIS

The following tables present information about our assets measured at fair value on a recurring basis and indicate the fair value hierarchy based on the levels of inputs we utilized to determine such fair value:

Fair Value Measurements UsingTotal Carried At Fair Value
(dollars in millions)Level 1Level 2Level 3
March 31, 2026    
Assets    
Cash equivalents in mutual funds$68 $— $— $68 
Cash equivalents in securities— 15 — 15 
Investment securities:    
Available-for-sale securities    
U.S. government and government sponsored entities— 13 — 13 
Obligations of states, municipalities, and political subdivisions
— 55 — 55 
Commercial paper— 13 — 13 
Non-U.S. government and government sponsored entities— 148 — 148 
Corporate debt5 1,039 3 1,047 
RMBS— 191 — 191 
CMBS— 18 — 18 
CDO/ABS— 70 — 70 
Total available-for-sale securities5 1,547 3 1,555 
Other securities   
Bonds:   
Corporate debt— 3 — 3 
CDO/ABS— 1 — 1 
Total bonds— 4 — 4 
Preferred stock12 — — 12 
Common stock42 — 1 43 
Total other securities54 4 1 59 
Total investment securities59 1,551 4 1,614 
Restricted cash equivalents in mutual funds612 — — 612 
Total$739 $1,566 $4 $2,309 
Fair Value Measurements UsingTotal Carried At Fair Value
(dollars in millions)Level 1Level 2Level 3
December 31, 2025    
Assets    
Cash equivalents in mutual funds$48 $— $— $48 
Cash equivalents in securities— 53 — 53 
Investment securities:    
Available-for-sale securities    
U.S. government and government sponsored entities— 13 — 13 
Obligations of states, municipalities, and political subdivisions
— 56 — 56 
Non-U.S. government and government sponsored entities— 157 — 157 
Corporate debt6 1,022 2 1,030 
RMBS— 190 — 190 
CMBS— 22 — 22 
CDO/ABS— 64 — 64 
Total available-for-sale securities6 1,524 2 1,532 
Other securities   
Bonds:    
Corporate debt— 3 — 3 
CDO/ABS— 3 — 3 
Total bonds— 6 — 6 
Preferred stock12 — — 12 
Common stock39 — 1 40 
Total other securities51 6 1 58 
Total investment securities57 1,530 3 1,590 
Restricted cash equivalents in mutual funds620 — — 620 
Total$725 $1,583 $3 $2,311 

Due to the insignificant activity within the Level 3 assets during the three months ended March 31, 2026 and 2025, we have omitted the additional disclosures relating to the changes in Level 3 assets measured at fair value on a recurring basis and the quantitative information about Level 3 unobservable inputs.

FAIR VALUE MEASUREMENTS — NON-RECURRING BASIS

We measure the fair value of certain assets on a non-recurring basis when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Net impairment charges recorded on assets measured at fair value on a non-recurring basis were immaterial during the three months ended March 31, 2026 and 2025.

FAIR VALUE MEASUREMENTS — VALUATION METHODOLOGIES AND ASSUMPTIONS

See Note 19 of the Notes to the Consolidated Financial Statements in Part II - Item 8 included in our Annual Report for information regarding our methods and assumptions used to estimate fair value.
v3.26.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Business and Basis of Presentation (Policies)
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION We prepared our condensed consolidated financial statements using generally accepted accounting principles in the United States of America (“GAAP”). These statements are unaudited. The year-end condensed consolidated balance sheet data was derived from our audited financial statements but does not include all disclosures required by GAAP.
CONSOLIDATION The statements include the accounts of OMH, its wholly-owned subsidiaries, and variable interest entities (“VIEs”) in which we hold a controlling financial interest and for which we are considered to be the primary beneficiary as of the financial statement date.We eliminated all material intercompany accounts and transactions.
USE OF ESTIMATES We made judgments, estimates, and assumptions that affect amounts reported in our condensed consolidated financial statements and disclosures of contingent assets and liabilities. In management’s opinion, the condensed consolidated financial statements include the normal, recurring adjustments necessary for a fair statement of results. Actual results could differ from our estimates. We evaluated the effects of and the need to disclose events that occurred subsequent to the balance sheet date.
ACCOUNTING PRONOUNCEMENTS TO BE ADOPTED
ACCOUNTING PRONOUNCEMENTS TO BE ADOPTED

Expense Disaggregation Disclosures

In December of 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires disclosure of certain costs and expenses in the notes to the financial statements. The amendments in this ASU will become effective for fiscal years beginning after December 15, 2026, and will be effective for interim periods with fiscal years beginning after December 15, 2027, with early adoption permitted. The amendments should be applied on a prospective basis, with retrospective application allowed. While the standard will not impact our consolidated financial results, we are currently evaluating the impact of the expanded disclosures.

We do not believe that any other accounting pronouncements issued, but not yet effective, are applicable or would have a material impact on our consolidated financial statements or disclosures, if adopted.
v3.26.1
Finance Receivables (Tables)
 3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Schedule of Components of Net Finance Receivables by Type
Components of our net finance receivables were as follows:
Consumer Loans
(dollars in millions)Personal Loans
Auto Finance
Total Consumer Loans
Credit CardsTotal
March 31, 2026
Gross finance receivables *$20,597 $2,514 $23,111 $970 $24,081 
Unearned fees
(252)(41)(293)— (293)
Accrued finance charges and fees358 27 385 — 385 
Deferred origination costs215 46 261 13 274 
Total$20,918 $2,546 $23,464 $983 $24,447 
December 31, 2025
Gross finance receivables *$21,086 $2,438 $23,524 $925 $24,449 
Unearned fees
(258)(42)(300)— (300)
Accrued finance charges and fees382 28 410 — 410 
Deferred origination costs220 43 263 11 274 
Total$21,430 $2,467 $23,897 $936 $24,833 
* Consumer loan gross finance receivables equal the unpaid principal balance net of unamortized discount or premium. For precompute personal loans, unpaid principal balance is the gross contractual payments less the unaccreted balance of unearned finance charges. Credit card gross finance receivables equal the unpaid principal balance, interest, and fees.
Schedule of Information Regarding Credit Quality Indicators
The following table below is a summary of finance charges on our consumer loans:
Three Months Ended March 31,
20262025
(dollars in millions)Personal Loans
Auto
Finance
Personal Loans
Auto
Finance
 
Net accrued finance charges reversed
$47 $3 $41 $3 
Finance charges recognized from the contractual interest portion of payments received on nonaccrual loans
6—6—
Net accrued finance charges and fees reversed on credit cards were as follows:
Three Months Ended March 31,
(dollars in millions)
20262025
Net accrued finance charges and fees reversed$23 $17 
Schedule of Net Finance Receivables by Type and by Days Delinquent
The following tables below are a summary of our personal loans by the year of origination and number of days delinquent:

(dollars in millions)20262025202420232022PriorTotal
March 31, 2026
Performing
Current$2,472 $8,826 $4,600 $2,321 $1,125 $458 $19,802 
30-59 days past due2 108 91 62 42 27 332 
60-89 days past due— 75 62 40 26 17 220 
Total performing2,474 9,009 4,753 2,423 1,193 502 20,354 
Nonperforming (Nonaccrual)
90+ days past due— 158 174 113 72 47 564 
Total$2,474 $9,167 $4,927 $2,536 $1,265 $549 $20,918 
Gross charge-offs *
$— $105 $179 $125 $73 $41 $523 
* Represents gross charge-offs for the three months ended March 31, 2026.

(dollars in millions)20252024202320222021PriorTotal
December 31, 2025
Performing
Current$10,149 $5,335 $2,759 $1,372 $439 $146 $20,200 
30-59 days past due101 120 85 60 29 12 407 
60-89 days past due63 82 53 36 17 7 258 
Total performing10,313 5,537 2,897 1,468 485 165 20,865 
Nonperforming (Nonaccrual)
90+ days past due99 191 135 86 38 16 565 
Total$10,412 $5,728 $3,032 $1,554 $523 $181 $21,430 
Gross charge-offs *
$— $86 $181 $136 $63 $26 $492 
* Represents gross charge-offs for the three months ended March 31, 2025.
The following tables below are a summary of our auto finance loans by the year of origination and number of days delinquent:

(dollars in millions)20262025202420232022PriorTotal
March 31, 2026
Performing
Current$341 $996 $602 $291 $129 $45 $2,404 
30-59 days past due1 33 27 14 10 5 90 
60-89 days past due— 9 6 3 2 1 21 
Total performing342 1,038 635 308 141 51 2,515 
Nonperforming (Nonaccrual)
90+ days past due— 10 10 6 3 2 31 
Total$342 $1,048 $645 $314 $144 $53 $2,546 
Gross charge-offs *
$— $13 $15 $8 $5 $2 $43 
* Represents gross charge-offs for the three months ended March 31, 2026.

(dollars in millions)20252024202320222021PriorTotal
December 31, 2025
Performing
Current$1,095 $667 $329 $152 $48 $9 $2,300 
30-59 days past due34 34 21 13 6 1 109 
60-89 days past due8 10 5 3 1 — 27 
Total performing1,137 711 355 168 55 10 2,436 
Nonperforming (Nonaccrual)
90+ days past due8 12 6 3 2 — 31 
Total$1,145 $723 $361 $171 $57 $10 $2,467 
Gross charge-offs *
$— $10 $11 $8 $3 $1 $33 
* Represents gross charge-offs for the three months ended March 31, 2025.

The following is a summary of credit cards by number of days delinquent:
(dollars in millions)March 31, 2026December 31, 2025
Current
$868 $820 
30-59 days past due
24 26 
60-89 days past due
23 24 
90+ days past due
68 66 
Total
$983 $936 
Schedule of Information Regarding Modified Finance Receivables
The period-end carrying value of net finance receivables modified during the period was as follows:
Three Months Ended March 31,
20262025
(dollars in millions)Personal Loans
Auto
 Finance
Personal Loans
Auto
 Finance
 
Interest rate reduction and term extension$106$8$95 $7
Interest rate reduction and principal forgiveness881119 —
Total modifications to borrowers experiencing financial difficulties$194$9$214 $7
Modifications as a percent of net finance receivables by class
0.93 %0.34 %1.04 %0.33 %

The financial effect of modifications made during the period was as follows:
Three Months Ended March 31,
20262025
(dollars in millions)Personal Loans
Auto
Finance
Personal Loans
Auto
Finance
 
Net finance receivables 
Weighted-average interest rate reduction21.02 %14.50 %16.14 %12.98 %
Weighted-average term extension (months)30192416
Principal/interest forgiveness$9$—$7 $—

The performance of finance receivables modified within the previous 12 months by delinquency status was as follows:
March 31, 2026 (a)March 31, 2025 (b)
(dollars in millions)Personal Loans
Auto
Finance
Personal Loans
Auto
Finance
Current
$523 $20 $515 $15 
30-59 days past due
44 3 51 2 
60-89 days past due32 1 36 1 
90+ days past due
74 2 79 1 
Total
$673 $26 $681 $19 
(a) Excludes $75 million of personal loan receivables that were modified and subsequently charged off within the previous 12 months. Auto finance receivables that were modified and subsequently charged off within the previous 12 months were immaterial.
(b) Excludes $99 million of personal loan receivables that were modified and subsequently charged off. Auto finance receivables that were modified and subsequently charged off were immaterial.
The period-end carrying value of finance receivables that defaulted during the period to cause the receivable to be considered nonperforming (90 days or more contractually past due) and had been modified within the 12 months preceding the default was as follows:
Three Months Ended March 31,
20262025
(dollars in millions)
Personal
Loans
Auto
 Finance
Personal Loans
Auto
 Finance
Interest rate reduction and term extension$35 $2 $31 $1 
Interest rate reduction and principal forgiveness19 — 19 — 
Total
$54 $2 $50 $1 
v3.26.1
Allowance for Finance Receivable Losses (Tables)
 3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Schedule of Changes in the Allowance for Finance Receivable Losses by Finance Receivable Type
Changes in the allowance for finance receivable losses were as follows:
(dollars in millions)
Consumer Loans
Credit CardsTotal
Three Months Ended March 31, 2026  
Balance at beginning of period$2,656 $209 $2,865 
Provision for finance receivable losses419 46 465 
Charge-offs(566)(49)(615)
Recoveries98 6 104 
Balance at end of period$2,607 $212 $2,819 
Three Months Ended March 31, 2025  
Balance at beginning of period$2,567 $138 $2,705 
Provision for finance receivable losses
409 47 456 
Charge-offs(525)(36)(561)
Recoveries85 3 88 
Balance at end of period$2,536 $152 $2,688 
v3.26.1
Investment Securities (Tables)
 3 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Schedule of the Cost/Amortized Cost, Unrealized Gains and Losses, and Fair Value of Available-for-sale Securities by Type
Cost/amortized cost, allowance for credit losses, unrealized gains and losses, and fair value of fixed maturity available-for-sale securities by type were as follows:
(dollars in millions)Cost/
Amortized
Cost		Unrealized
Gains		Unrealized
Losses		Fair
Value
March 31, 2026*    
Fixed maturity available-for-sale securities:    
U.S. government and government sponsored entities$13 $— $— $13 
Obligations of states, municipalities, and political subdivisions
58 — (3)55 
Commercial paper
13 — — 13 
Non-U.S. government and government sponsored entities
150 1 (3)148 
Corporate debt
1,088 6 (47)1,047 
Mortgage-backed, asset-backed, and collateralized:
   
RMBS
207 1 (17)191 
CMBS
20 — (2)18 
CDO/ABS
72 — (2)70 
Total$1,621 $8 $(74)$1,555 
December 31, 2025*
Fixed maturity available-for-sale securities:
U.S. government and government sponsored entities
$13 $— $— $13 
 Obligations of states, municipalities, and political subdivisions
59 — (3)56 
Commercial paper— — — — 
Non-U.S. government and government sponsored entities159 1 (3)157 
Corporate debt1,057 11 (38)1,030 
Mortgage-backed, asset-backed, and collateralized:
RMBS206 1 (17)190 
CMBS24 — (2)22 
CDO/ABS66 — (2)64 
Total$1,584 $13 $(65)$1,532 
*    The allowance for credit losses related to our investment securities as of March 31, 2026 and December 31, 2025 was immaterial.
Schedule of Fair Value and Unrealized Losses on Investment Securities by Type and Length of Time In a Continuous Unrealized Loss Position
Fair value and unrealized losses on available-for-sale securities by type and length of time in a continuous unrealized loss position without an allowance for credit losses were as follows:
 Less Than 12 Months12 Months or LongerTotal
(dollars in millions)Fair
Value
Unrealized
Losses
Fair
Value		Unrealized
Losses		Fair
Value		Unrealized
Losses
March 31, 2026      
U.S. government and government sponsored entities
$— $— $8 $— $8 $— 
Obligations of states, municipalities, and political subdivisions
4 — 45 (3)49 (3)
Non-U.S. government and government sponsored entities
50 — 34 (3)84 (3)
Corporate debt279 (4)503 (43)782 (47)
Mortgage-backed, asset-backed, and collateralized:
RMBS27 — 121 (17)148 (17)
CMBS3 — 15 (2)18 (2)
CDO/ABS25 — 23 (2)48 (2)
Total$388 $(4)$749 $(70)$1,137 $(74)
December 31, 2025
      
U.S. government and government sponsored entities
$— $— $8 $— $8 $— 
Obligations of states, municipalities, and political subdivisions
1 — 48 (3)49 (3)
Non-U.S. government and government sponsored entities
23 — 37 (3)60 (3)
Corporate debt73 — 545 (38)618 (38)
Mortgage-backed, asset-backed, and collateralized:
RMBS6 — 124 (17)130 (17)
CMBS1 — 19 (2)20 (2)
CDO/ABS6 — 28 (2)34 (2)
Total$110 $— $809 $(65)$919 $(65)
Schedule of Contractual Maturities of Fixed-Maturity Available-for-sale Securities
Contractual maturities of fixed-maturity available-for-sale securities at March 31, 2026 were as follows:
(dollars in millions)Fair
Value		Amortized
Cost
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities:
  
Due in 1 year or less$152 $152 
Due after 1 year through 5 years606 624 
Due after 5 years through 10 years375 387 
Due after 10 years143 159 
Mortgage-backed, asset-backed, and collateralized securities279 299 
Total$1,555 $1,621 
Schedule of Fair Value of Other Securities by Type
The fair value of other securities by type was as follows:
(dollars in millions)March 31, 2026December 31, 2025
Fixed maturity other securities: 
Bonds$4 $6 
Preferred stock
12 12 
Common stock
43 40 
Total $59 $58 
v3.26.1
Long-term Debt (Tables)
 3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Principal Maturities of Long-term Debt
Principal maturities of long-term debt by type of debt at March 31, 2026 were as follows:
Senior Debt
(dollars in millions)Securitizations
Private Secured Term Funding
Revolving
Conduit
Facilities		Unsecured
Notes (a)		Junior
Subordinated
Debt (a)		Total
Interest rates (b)
1.55%-10.98%
4.88%
4.80%
3.50%-7.88%
5.68 %
Remainder of 2026$— $— $— $— $— $— 
2027— — — 750 — 750 
2028— — — 1,350 — 1,350 
2029— — — 1,640 — 1,640 
2030— — — 2,292 — 2,292 
2031-2067— — — 4,700 350 5,050 
Secured (c)11,274 350 1 — — 11,625 
Total principal maturities$11,274 $350 $1 $10,732 $350 $22,707 
Total carrying amount$11,236 $349 $1 $10,637 $173 $22,396 
Debt issuance costs (d)(36)(1)— (92)— (129)
(a) Pursuant to the Base Indenture, the Supplemental Indentures, and the Guaranty Agreements, OMH agreed to fully and unconditionally guarantee, on a senior unsecured basis, payments of principal, premium and interest on the Unsecured Notes and Junior Subordinated Debenture. The OMH guarantees of OMFC’s long-term debt are subject to customary release provisions.
(b) The interest rates shown are the range of contractual rates in effect at March 31, 2026.
(c) Securitizations, private secured term funding, and borrowings under the revolving conduit facilities are not included in the above maturities by period due to their variable monthly repayments, which may result in pay-off prior to the stated maturity date. See Note 7 for further information on our long-term debt associated with securitizations, private secured term funding, and revolving conduit facilities.
(d) Debt issuance costs are reported as a direct reduction from long-term debt, with the exception of debt issuance costs associated with our revolving conduit facilities, credit card revolving variable funding note (“VFN”) facilities, and the unsecured corporate revolver, which totaled $34 million at March 31, 2026 and are reported in Other assets in our condensed consolidated balance sheets.
v3.26.1
Variable Interest Entities (Tables)
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Carrying Amounts of Consolidated VIE Assets and Liabilities The carrying amounts of consolidated VIE assets and liabilities associated with our securitization trusts, private secured term funding, revolving conduit facilities, and credit card revolving VFN facilities were as follows:
(dollars in millions)March 31, 2026December 31, 2025
Assets  
Cash and cash equivalents$5 $5 
Net finance receivables13,526 13,418 
Allowance for finance receivable losses1,536 1,558 
Restricted cash and restricted cash equivalents717 690 
Other assets42 41 
Liabilities  
Long-term debt$11,586 $11,464 
Other liabilities29 30 
v3.26.1
Insurance (Tables)
 3 Months Ended
Mar. 31, 2026
Insurance [Abstract]  
Schedule of Changes in the Reserve for Unpaid Claims and Loss Adjustment Expenses
Changes in the reserve for unpaid claims and loss adjustment expenses (net of reinsurance recoverables) on our short-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
(dollars in millions)20262025
Balance at beginning of period$98 $102 
Less reinsurance recoverables(3)(3)
Net balance at beginning of period95 99 
Additions for losses and loss adjustment expenses incurred to:
Current year53 52 
Prior years *
(2)(6)
Total51 46 
Reductions for losses and loss adjustment expenses paid related to:
Current year(17)(17)
Prior years(34)(32)
Total(51)(49)
Net balance at end of period95 96 
Plus reinsurance recoverables3 2 
Balance at end of period$98 $98 
*    At March 31, 2026, there were redundancies in the prior years’ net reserves due to favorable developments of credit life claims during the period. At March 31, 2025, there were redundancies in the prior years’ net reserves due to favorable developments of credit disability claims during the period.
Schedule of Liability for Future Policy Benefit, Activity
The present values of expected net premiums on long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
 Whole Life		Accidental Death and Disability ProtectionTerm and
 Whole Life		Accidental Death and Disability Protection
Balance at beginning of period$138 $28 $177 $33 
Effect of cumulative changes in discount rate assumptions (beginning of period)(3)— (2)— 
Beginning balance at original discount rate135 28 175 33 
Effect of actual variances from expected experience(1)(2)(3)— 
Adjusted balance at beginning of period134 26 172 33 
Interest accretion2 — 2 — 
Net premiums collected(6)(1)(6)(1)
Ending balance at original discount rate130 25 168 32 
Effect of changes in discount rate assumptions1 — 1 (1)
Balance at ending of period$131 $25 $169 $31 
The present values of expected future policy benefits on long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Balance at beginning of period$329 $90 $378 $96 
Effect of cumulative changes in discount rate assumptions (beginning of period)(9)1(5)2
Beginning balance at original discount rate3209137398
Effect of actual variances from expected experience(2)(4)(2)(1)
Adjusted balance at beginning of period3188737197
Net issuances1—1—
Interest accretion4151
Benefit payments(10)(2)(13)(3)
Ending balance at original discount rate3138636495
Effect of changes in discount rate assumptions4(1)3(2)
Balance at ending of period$317 $85 $367 $93 

The net liabilities for future policy benefits on long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Net liability for future policy benefits$186 $60 $198 $62 
Deferred profit liability12431147
Total net liability for future policy benefits$198 $103 $209 $109 
The following table reconciles the net liability for future policy benefits to Insurance claims and policyholder liabilities in the condensed consolidated balance sheets:
At or for the
Three Months Ended March 31,
(dollars in millions)20262025
Term and whole life$198 $209 
Accidental death and disability protection103 109 
Other*265 249 
Total insurance claims and policyholder liabilities
$566 $567 
*    Other primarily includes reserves for short-duration contracts that are payable to third-party beneficiaries.
The undiscounted and discounted expected future gross premiums and expected future benefits and expenses for our long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Expected future gross premiums:
Undiscounted$273 $96 $352 $119 
Discounted206 69 254 85 
Expected future benefit payments:
Undiscounted429 124 514 140 
Discounted317 85 367 93 

The revenue and interest accretion related to our long-duration insurance contracts recognized in the condensed consolidated statements of operations were as follows:
At or for the
Three Months Ended March 31,
20262025
(dollars in millions)Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Gross premiums or assessments$11 $3 $12 $4 
Interest accretion$2 $1 $3 $1 
The weighted-average interest rates for the liability of future policy benefits for our long-duration insurance contracts were as follows:
At or for the
Three Months Ended March 31,
20262025
Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Interest accretion rate5.28 %4.85 %5.29 %4.86 %
Current discount rate5.40 %5.58 %5.40 %5.49 %
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The expected and actual experiences for mortality, morbidity, and lapses of the liability for future policy benefits were as follows:
At or for the
Three Months Ended March 31,
20262025
Term and
Whole Life		Accidental Death and Disability ProtectionTerm and
Whole Life		Accidental Death and Disability Protection
Mortality/Morbidity:
Expected0.41 %0.02 %0.39 %0.01 %
Actual0.37 %0.01 %0.41 %0.01 %
Lapses:
Expected3.85 %1.60 %3.79 %1.71 %
Actual4.16 %3.93 %3.00 %2.38 %
v3.26.1
Capital Stock and Earnings Per Share (OMH Only) (Tables)
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Changes in Shares Issued and Outstanding
Changes in OMH shares of common stock issued and outstanding were as follows:
Three Months Ended March 31,
20262025
Balance at beginning of period117,196,792 119,360,509 
Common stock issued 312,854 223,914 
Common stock repurchased(1,901,698)(323,176)
Treasury stock issued19,313 20,313 
Balance at end of period115,627,261 119,281,560 
Schedule of Computation of Earnings Per Share
The computation of earnings per share was as follows:
Three Months Ended March 31,
(dollars in millions, except per share data)20262025
 
Numerator (basic and diluted):  
Net income$226 $213 
Denominator:  
Weighted average number of shares outstanding (basic)116,724,709 119,399,008 
Effect of dilutive securities *547,895 570,705 
Weighted average number of shares outstanding (diluted)117,272,604 119,969,713 
Earnings per share:  
Basic$1.93 $1.79 
Diluted$1.93 $1.78 
* We have excluded weighted-average unvested restricted stock units totaling 494,273 and 777,055 for the three months ended March 31, 2026 and 2025, respectively, from the fully-diluted earnings per share calculations as these shares would be anti-dilutive, which could impact the earnings per share calculation in the future.
v3.26.1
Accumulated Other Comprehensive Income (Loss) (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Changes, Net of Tax, in Accumulated Other Comprehensive Income (Loss)
Changes, net of tax, in Accumulated other comprehensive income (loss) were as follows:
(dollars in millions)Unrealized
Gains (Losses)
Available-for-Sale Securities (a)		Retirement
Plan Liabilities
Adjustments		Foreign
Currency
Translation
Adjustments
Changes in Discount Rate for Insurance Claims and Policyholder Liabilities
Other (b)Total
Accumulated
Other
Comprehensive
Income (Loss)
Three Months Ended
March 31, 2026		    
Balance at beginning of period$(41)$(2)$(7)$(3)$12 $(41)
Other comprehensive income (loss) before reclassifications
(12)— (1)2 (1)(12)
Balance at end of period$(53)$(2)$(8)$(1)$11 $(53)
Three Months Ended
March 31, 2025		    
Balance at beginning of period$(81)$(3)$(13)$(1)$17 $(81)
Other comprehensive income (loss) before reclassifications
16 — — 1 (1)16 
Balance at end of period$(65)$(3)$(13)$— $16 $(65)
(a) There were no material amounts related to available-for-sale debt securities for which an allowance for credit losses was recorded during the three months ended March 31, 2026 and 2025.
(b) Other primarily includes changes in the fair value of our mark-to-market derivative instruments that have been designated as cash flow hedges.
v3.26.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Information About the Company's Segments
The following tables present information about C&I and Other, as well as reconciliations to the condensed consolidated financial statement amounts.
(dollars in millions)Consumer
and
Insurance		OtherSegment to
GAAP
Adjustment		Consolidated
Total
Three Months Ended March 31, 2026  
Interest income$1,383 $1 $3 $1,387 
Interest expense322 — — 322 
Provision for finance receivable losses
465 — — 465 
Net interest income after provision for finance receivable losses
596 1 3 600 
Other revenues195 2 — 197 
Salaries and benefits
239 1 — 240 
Other operating expenses
207 2 — 209 
Insurance policy benefits and claims
52 — — 52 
Income before income tax expense
$293 $— $3 $296 
Assets$25,869 $6 $1,143 $27,018 
Three Months Ended March 31, 2025
Interest income$1,301 $1 $6 $1,308 
Interest expense311 — 1 312 
Provision for finance receivable losses
456 — — 456 
Net interest income after provision for finance receivable losses
534 1 5 540 
Other revenues186 2 — 188 
Salaries and benefits
217 1 — 218 
Other operating expenses
184 1 1 186 
Insurance policy benefits and claims
49 — — 49 
Income before income tax expense
$270 $1 $4 $275 
Assets$24,889 $11 $1,129 $26,029 
v3.26.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Carrying amounts and Estimated Fair Values of Financial Instruments and Fair Value Hierarchy Based on the Level of Inputs Utilized to Determine Such Fair Value
The following table presents the carrying amounts and estimated fair values of our financial instruments and indicates the level in the fair value hierarchy of the estimated fair value measurement based on the observability of the inputs used:
Fair Value Measurements UsingTotal
Fair
Value		Total
Carrying
Value
(dollars in millions)Level 1Level 2Level 3
March 31, 2026
Assets
Cash and cash equivalents$819 $15 $— $834 $834 
Investment securities59 1,551 4 1,614 1,614 
Net finance receivables, less allowance for finance receivable losses
— — 24,036 24,036 21,628 
Restricted cash and restricted cash equivalents 728 — — 728 728 
Other assets *
— — 31 31 17 
Liabilities
Long-term debt $— $22,369 $— $22,369 $22,396 
December 31, 2025
Assets
Cash and cash equivalents$860 $54 $— $914 $914 
Investment securities57 1,530 3 1,590 1,590 
Net finance receivables, less allowance for finance receivable losses
— — 24,440 24,440 21,968 
Restricted cash and restricted cash equivalents 699 — — 699 699 
Other assets *
— — 31 31 18 
Liabilities
Long-term debt$— $23,204 $— $23,204 $22,694 
*Other assets at March 31, 2026 and December 31, 2025 primarily consists of finance receivables held for sale.
Schedule of Assets Measured at Fair Value on a Recurring Basis
The following tables present information about our assets measured at fair value on a recurring basis and indicate the fair value hierarchy based on the levels of inputs we utilized to determine such fair value:

Fair Value Measurements UsingTotal Carried At Fair Value
(dollars in millions)Level 1Level 2Level 3
March 31, 2026    
Assets    
Cash equivalents in mutual funds$68 $— $— $68 
Cash equivalents in securities— 15 — 15 
Investment securities:    
Available-for-sale securities    
U.S. government and government sponsored entities— 13 — 13 
Obligations of states, municipalities, and political subdivisions
— 55 — 55 
Commercial paper— 13 — 13 
Non-U.S. government and government sponsored entities— 148 — 148 
Corporate debt5 1,039 3 1,047 
RMBS— 191 — 191 
CMBS— 18 — 18 
CDO/ABS— 70 — 70 
Total available-for-sale securities5 1,547 3 1,555 
Other securities   
Bonds:   
Corporate debt— 3 — 3 
CDO/ABS— 1 — 1 
Total bonds— 4 — 4 
Preferred stock12 — — 12 
Common stock42 — 1 43 
Total other securities54 4 1 59 
Total investment securities59 1,551 4 1,614 
Restricted cash equivalents in mutual funds612 — — 612 
Total$739 $1,566 $4 $2,309 
Fair Value Measurements UsingTotal Carried At Fair Value
(dollars in millions)Level 1Level 2Level 3
December 31, 2025    
Assets    
Cash equivalents in mutual funds$48 $— $— $48 
Cash equivalents in securities— 53 — 53 
Investment securities:    
Available-for-sale securities    
U.S. government and government sponsored entities— 13 — 13 
Obligations of states, municipalities, and political subdivisions
— 56 — 56 
Non-U.S. government and government sponsored entities— 157 — 157 
Corporate debt6 1,022 2 1,030 
RMBS— 190 — 190 
CMBS— 22 — 22 
CDO/ABS— 64 — 64 
Total available-for-sale securities6 1,524 2 1,532 
Other securities   
Bonds:    
Corporate debt— 3 — 3 
CDO/ABS— 3 — 3 
Total bonds— 6 — 6 
Preferred stock12 — — 12 
Common stock39 — 1 40 
Total other securities51 6 1 58 
Total investment securities57 1,530 3 1,590 
Restricted cash equivalents in mutual funds620 — — 620 
Total$725 $1,583 $3 $2,311 
v3.26.1
Finance Receivables - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Whole loan sale flow agreement, loans committed to sell $ 2,100    
Whole loan sale flow agreement, commitment period (less than) 3 years    
Proceeds from sale of gross finance receivables $ 341 $ 255  
Gain on sale of financing receivables 16 $ 16  
Unused credit card lines $ 619   $ 500
Credit Cards      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Threshold period past due 180 days    
Unlikely to be Collected Financing Receivable | Total Consumer Loans      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Threshold period past due 60 days    
Nonperforming (Nonaccrual) | Total Consumer Loans      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Threshold period past due 90 days    
Minimum | Personal Loans      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Finance receivables, original term 3 years    
Minimum | Auto Finance      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Finance receivables, original term 3 years    
Maximum | Personal Loans      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Finance receivables, original term 6 years    
Maximum | Auto Finance      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Finance receivables, original term 6 years    
v3.26.1
Finance Receivables - Schedule of Net Finance Receivables by Type (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Gross finance receivables $ 24,081 $ 24,449
Unearned fees (293) (300)
Accrued finance charges and fees 385 410
Deferred origination costs 274 274
Total 24,447 24,833
Total Consumer Loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Gross finance receivables 23,111 23,524
Unearned fees (293) (300)
Accrued finance charges and fees 385 410
Deferred origination costs 261 263
Total 23,464 23,897
Personal Loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Gross finance receivables 20,597 21,086
Unearned fees (252) (258)
Accrued finance charges and fees 358 382
Deferred origination costs 215 220
Total 20,918 21,430
Auto Finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Gross finance receivables 2,514 2,438
Unearned fees (41) (42)
Accrued finance charges and fees 27 28
Deferred origination costs 46 43
Total 2,546 2,467
Credit Cards    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Gross finance receivables 970 925
Unearned fees 0 0
Accrued finance charges and fees 0 0
Deferred origination costs 13 11
Total $ 983 $ 936
v3.26.1
Finance Receivables - Schedule of Finance Charges on Consumer Loans (Details) - Nonperforming (Nonaccrual) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Personal Loans    
Financing Receivable, Modified [Line Items]    
Net accrued finance charges reversed $ 47 $ 41
Finance charges recognized from the contractual interest portion of payments received on nonaccrual loans 6 6
Auto Finance    
Financing Receivable, Modified [Line Items]    
Net accrued finance charges reversed 3 3
Finance charges recognized from the contractual interest portion of payments received on nonaccrual loans $ 0 $ 0
v3.26.1
Finance Receivables - Schedule of Finance Charges and Fees Reversed on Credit Cards (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Credit Cards | Nonperforming (Nonaccrual)    
Financing Receivable, Modified [Line Items]    
Net accrued finance charges and fees reversed $ 23 $ 17
v3.26.1
Finance Receivables - Schedule of Delinquent and Nonperforming Finance Receivables, by Year of Origination (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Financing Receivable By Year Originated      
Total $ 24,447   $ 24,833
Gross charge-offs      
Total 615 $ 561  
Personal Loans      
Financing Receivable By Year Originated      
Year one 2,474   10,412
Prior year two 9,167   5,728
Prior year three 4,927   3,032
Prior year four 2,536   1,554
Prior year five 1,265   523
Prior year six 549   181
Total 20,918   21,430
Gross charge-offs      
Year one 0 0  
Prior year two 105 86  
Prior year three 179 181  
Prior year four 125 136  
Prior year five 73 63  
Prior year six 41 26  
Total 523 492  
Auto Finance      
Financing Receivable By Year Originated      
Year one 342   1,145
Prior year two 1,048   723
Prior year three 645   361
Prior year four 314   171
Prior year five 144   57
Prior year six 53   10
Total 2,546   2,467
Gross charge-offs      
Year one 0 0  
Prior year two 13 10  
Prior year three 15 11  
Prior year four 8 8  
Prior year five 5 3  
Prior year six 2 1  
Total 43 $ 33  
Performing | Personal Loans      
Financing Receivable By Year Originated      
Year one 2,474   10,313
Prior year two 9,009   5,537
Prior year three 4,753   2,897
Prior year four 2,423   1,468
Prior year five 1,193   485
Prior year six 502   165
Total 20,354   20,865
Performing | Auto Finance      
Financing Receivable By Year Originated      
Year one 342   1,137
Prior year two 1,038   711
Prior year three 635   355
Prior year four 308   168
Prior year five 141   55
Prior year six 51   10
Total 2,515   2,436
Performing | Current | Personal Loans      
Financing Receivable By Year Originated      
Year one 2,472   10,149
Prior year two 8,826   5,335
Prior year three 4,600   2,759
Prior year four 2,321   1,372
Prior year five 1,125   439
Prior year six 458   146
Total 19,802   20,200
Performing | Current | Auto Finance      
Financing Receivable By Year Originated      
Year one 341   1,095
Prior year two 996   667
Prior year three 602   329
Prior year four 291   152
Prior year five 129   48
Prior year six 45   9
Total 2,404   2,300
Performing | 30-59 days past due | Personal Loans      
Financing Receivable By Year Originated      
Year one 2   101
Prior year two 108   120
Prior year three 91   85
Prior year four 62   60
Prior year five 42   29
Prior year six 27   12
Total 332   407
Performing | 30-59 days past due | Auto Finance      
Financing Receivable By Year Originated      
Year one 1   34
Prior year two 33   34
Prior year three 27   21
Prior year four 14   13
Prior year five 10   6
Prior year six 5   1
Total 90   109
Performing | 60-89 days past due | Personal Loans      
Financing Receivable By Year Originated      
Year one 0   63
Prior year two 75   82
Prior year three 62   53
Prior year four 40   36
Prior year five 26   17
Prior year six 17   7
Total 220   258
Performing | 60-89 days past due | Auto Finance      
Financing Receivable By Year Originated      
Year one 0   8
Prior year two 9   10
Prior year three 6   5
Prior year four 3   3
Prior year five 2   1
Prior year six 1   0
Total 21   27
Nonperforming (Nonaccrual) | 90+ days past due | Personal Loans      
Financing Receivable By Year Originated      
Year one 0   99
Prior year two 158   191
Prior year three 174   135
Prior year four 113   86
Prior year five 72   38
Prior year six 47   16
Total 564   565
Nonperforming (Nonaccrual) | 90+ days past due | Auto Finance      
Financing Receivable By Year Originated      
Year one 0   8
Prior year two 10   12
Prior year three 10   6
Prior year four 6   3
Prior year five 3   2
Prior year six 2   0
Total $ 31   $ 31
v3.26.1
Finance Receivables - Schedule of Credit Cards by Number of Days Delinquent (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Delinquency by finance receivables type    
Net finance receivables $ 24,447 $ 24,833
Credit Cards    
Delinquency by finance receivables type    
Net finance receivables 983 936
Credit Cards | Current    
Delinquency by finance receivables type    
Net finance receivables 868 820
Credit Cards | 30-59 days past due    
Delinquency by finance receivables type    
Net finance receivables 24 26
Credit Cards | 60-89 days past due    
Delinquency by finance receivables type    
Net finance receivables 23 24
Credit Cards | 90+ days past due    
Delinquency by finance receivables type    
Net finance receivables $ 68 $ 66
v3.26.1
Finance Receivables - Schedule of Modified Financing Receivables To Borrowers Experiencing Financial Difficulty (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Personal Loans    
Financing Receivable, Modified [Line Items]    
Total modifications to borrowers experiencing financial difficulties $ 194 $ 214
Modifications as a percent of net finance receivables by class 0.93% 1.04%
Personal Loans | Interest rate reduction and term extension    
Financing Receivable, Modified [Line Items]    
Total modifications to borrowers experiencing financial difficulties $ 106 $ 95
Personal Loans | Interest rate reduction and principal forgiveness    
Financing Receivable, Modified [Line Items]    
Total modifications to borrowers experiencing financial difficulties 88 119
Auto Finance    
Financing Receivable, Modified [Line Items]    
Total modifications to borrowers experiencing financial difficulties $ 9 $ 7
Modifications as a percent of net finance receivables by class 0.34% 0.33%
Auto Finance | Interest rate reduction and term extension    
Financing Receivable, Modified [Line Items]    
Total modifications to borrowers experiencing financial difficulties $ 8 $ 7
Auto Finance | Interest rate reduction and principal forgiveness    
Financing Receivable, Modified [Line Items]    
Total modifications to borrowers experiencing financial difficulties $ 1 $ 0
v3.26.1
Finance Receivables - Schedule of Modified Financing Receivables Financial Effects (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Personal Loans    
Financing Receivable, Modified [Line Items]    
Weighted-average interest rate reduction 21.02% 16.14%
Weighted-average term extension (months) 30 months 24 months
Principal/interest forgiveness $ 9 $ 7
Auto Finance    
Financing Receivable, Modified [Line Items]    
Weighted-average interest rate reduction 14.50% 12.98%
Weighted-average term extension (months) 19 months 16 months
Principal/interest forgiveness $ 0 $ 0
v3.26.1
Finance Receivables - Schedule of Modified Financing Receivables Days Delinquent (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Personal Loans    
Financing Receivable, Modified [Line Items]    
Modified financing receivables $ 673 $ 681
Finance receivables subsequently charged off 75 99
Auto Finance    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 26 19
Current | Personal Loans    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 523 515
Current | Auto Finance    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 20 15
30-59 days past due | Personal Loans    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 44 51
30-59 days past due | Auto Finance    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 3 2
60-89 days past due | Personal Loans    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 32 36
60-89 days past due | Auto Finance    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 1 1
90+ days past due | Personal Loans    
Financing Receivable, Modified [Line Items]    
Modified financing receivables 74 79
90+ days past due | Auto Finance    
Financing Receivable, Modified [Line Items]    
Modified financing receivables $ 2 $ 1
v3.26.1
Finance Receivables - Schedule of Modified Finance Receivables, Nonperforming (Details) - Nonperforming (Nonaccrual) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Personal Loans    
Financing Receivable, Modified [Line Items]    
Modified finance receivables $ 54 $ 50
Personal Loans | Interest rate reduction and term extension    
Financing Receivable, Modified [Line Items]    
Modified finance receivables 35 31
Personal Loans | Interest rate reduction and principal forgiveness    
Financing Receivable, Modified [Line Items]    
Modified finance receivables 19 19
Auto Finance    
Financing Receivable, Modified [Line Items]    
Modified finance receivables 2 1
Auto Finance | Interest rate reduction and term extension    
Financing Receivable, Modified [Line Items]    
Modified finance receivables 2 1
Auto Finance | Interest rate reduction and principal forgiveness    
Financing Receivable, Modified [Line Items]    
Modified finance receivables $ 0 $ 0
v3.26.1
Allowance for Finance Receivable Losses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Changes in allowance for finance receivable losses    
Balance at beginning of period $ 2,865 $ 2,705
Provision for finance receivable losses 465 456
Charge-offs (615) (561)
Recoveries 104 88
Balance at end of period 2,819 2,688
Consumer Loans    
Changes in allowance for finance receivable losses    
Balance at beginning of period 2,656 2,567
Provision for finance receivable losses 419 409
Charge-offs (566) (525)
Recoveries 98 85
Balance at end of period 2,607 2,536
Credit Cards    
Changes in allowance for finance receivable losses    
Balance at beginning of period 209 138
Provision for finance receivable losses 46 47
Charge-offs (49) (36)
Recoveries 6 3
Balance at end of period $ 212 $ 152
v3.26.1
Investment Securities - Schedule of Cost/Amortized, Unrealized Gains/Losses & FV on AFS Investment Securities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost $ 1,621 $ 1,584
Unrealized Gains 8 13
Unrealized Losses (74) (65)
Fair Value 1,555 1,532
U.S. government and government sponsored entities    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 13 13
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 13 13
Obligations of states, municipalities, and political subdivisions    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 58 59
Unrealized Gains 0 0
Unrealized Losses (3) (3)
Fair Value 55 56
Commercial paper    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 13 0
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 13 0
Non-U.S. government and government sponsored entities    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 150 159
Unrealized Gains 1 1
Unrealized Losses (3) (3)
Fair Value 148 157
Corporate debt    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 1,088 1,057
Unrealized Gains 6 11
Unrealized Losses (47) (38)
Fair Value 1,047 1,030
RMBS    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 207 206
Unrealized Gains 1 1
Unrealized Losses (17) (17)
Fair Value 191 190
CMBS    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 20 24
Unrealized Gains 0 0
Unrealized Losses (2) (2)
Fair Value 18 22
CDO/ABS    
Debt Securities, Available-for-sale [Line Items]    
Cost/ Amortized Cost 72 66
Unrealized Gains 0 0
Unrealized Losses (2) (2)
Fair Value $ 70 $ 64
v3.26.1
Investment Securities - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2026
USD ($)
investment
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
investment
Investments, Debt and Equity Securities [Abstract]      
Interest receivable $ 14   $ 14
Number of investment securities in an unrealized loss position | investment 1,563   1,355
Proceeds from sales and redemptions $ 38 $ 22  
Securities on deposit with third parties $ 510   $ 490
v3.26.1
Investment Securities - Schedule of Fair Value and Unrealized Losses on AFS Investment Securities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Fair Value    
Less Than 12 Months $ 388 $ 110
12 Months or Longer 749 809
Total 1,137 919
Unrealized Losses    
Less Than 12 Months (4) 0
12 Months or Longer (70) (65)
Total (74) (65)
U.S. government and government sponsored entities    
Fair Value    
Less Than 12 Months 0 0
12 Months or Longer 8 8
Total 8 8
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or Longer 0 0
Total 0 0
Obligations of states, municipalities, and political subdivisions    
Fair Value    
Less Than 12 Months 4 1
12 Months or Longer 45 48
Total 49 49
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or Longer (3) (3)
Total (3) (3)
Non-U.S. government and government sponsored entities    
Fair Value    
Less Than 12 Months 50 23
12 Months or Longer 34 37
Total 84 60
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or Longer (3) (3)
Total (3) (3)
Corporate debt    
Fair Value    
Less Than 12 Months 279 73
12 Months or Longer 503 545
Total 782 618
Unrealized Losses    
Less Than 12 Months (4) 0
12 Months or Longer (43) (38)
Total (47) (38)
RMBS    
Fair Value    
Less Than 12 Months 27 6
12 Months or Longer 121 124
Total 148 130
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or Longer (17) (17)
Total (17) (17)
CMBS    
Fair Value    
Less Than 12 Months 3 1
12 Months or Longer 15 19
Total 18 20
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or Longer (2) (2)
Total (2) (2)
CDO/ABS    
Fair Value    
Less Than 12 Months 25 6
12 Months or Longer 23 28
Total 48 34
Unrealized Losses    
Less Than 12 Months 0 0
12 Months or Longer (2) (2)
Total $ (2) $ (2)
v3.26.1
Investment Securities - Schedule of Contractual Maturities of AFS Investment Securities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities:    
Due in 1 year or less $ 152  
Due after 1 year through 5 years 606  
Due after 5 years through 10 years 375  
Due after 10 years 143  
Mortgage-backed, asset-backed, and collateralized securities 279  
Fair Value 1,555 $ 1,532
Fixed maturities, excluding mortgage-backed, asset-backed, and collateralized securities:    
Due in 1 year or less 152  
Due after 1 year through 5 years 624  
Due after 5 years through 10 years 387  
Due after 10 years 159  
Mortgage-backed, asset-backed, and collateralized securities 299  
Cost/ Amortized Cost $ 1,621 $ 1,584
v3.26.1
Investment Securities - Schedule of Fair Value of Other Securities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Debt and Equity Securities, FV-NI [Line Items]    
Bonds $ 4 $ 6
Total 59 58
Preferred stock    
Debt and Equity Securities, FV-NI [Line Items]    
Equity securities 12 12
Common stock    
Debt and Equity Securities, FV-NI [Line Items]    
Equity securities $ 43 $ 40
v3.26.1
Long-term Debt - Schedule of Principal Maturities of Long-Term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Principal maturities of long-term debt by type of debt    
Remainder of 2026 $ 0  
2027 750  
2028 1,350  
2029 1,640  
2030 2,292  
2031-2067 5,050  
Secured 11,625  
Total principal maturities 22,707  
Total carrying amount 22,396 $ 22,694
Debt issuance costs (129)  
Securitizations    
Principal maturities of long-term debt by type of debt    
Remainder of 2026 0  
2027 0  
2028 0  
2029 0  
2030 0  
2031-2067 0  
Secured 11,274  
Total principal maturities 11,274  
Total carrying amount 11,236  
Debt issuance costs $ (36)  
Securitizations | Minimum    
Debt Instrument [Line Items]    
Interest rate 1.55%  
Securitizations | Maximum    
Debt Instrument [Line Items]    
Interest rate 10.98%  
Private Secured Term Funding    
Debt Instrument [Line Items]    
Interest rate 4.88%  
Principal maturities of long-term debt by type of debt    
Remainder of 2026 $ 0  
2027 0  
2028 0  
2029 0  
2030 0  
2031-2067 0  
Secured 350  
Total principal maturities 350  
Total carrying amount 349  
Debt issuance costs $ (1)  
Revolving Conduit Facilities    
Debt Instrument [Line Items]    
Interest rate 4.80%  
Principal maturities of long-term debt by type of debt    
Remainder of 2026 $ 0  
2027 0  
2028 0  
2029 0  
2030 0  
2031-2067 0  
Secured 1  
Total principal maturities 1  
Total carrying amount 1  
Debt issuance costs 0  
Revolving Conduit Facilities And Unsecured Corporate Revolver    
Principal maturities of long-term debt by type of debt    
Debt issuance costs 34  
Senior debt | Unsecured Notes    
Principal maturities of long-term debt by type of debt    
Remainder of 2026 0  
2027 750  
2028 1,350  
2029 1,640  
2030 2,292  
2031-2067 4,700  
Secured 0  
Total principal maturities 10,732  
Total carrying amount 10,637  
Debt issuance costs $ (92)  
Senior debt | Unsecured Notes | Minimum    
Debt Instrument [Line Items]    
Interest rate 3.50%  
Senior debt | Unsecured Notes | Maximum    
Debt Instrument [Line Items]    
Interest rate 7.88%  
Junior subordinated debt    
Debt Instrument [Line Items]    
Interest rate 5.68%  
Principal maturities of long-term debt by type of debt    
Remainder of 2026 $ 0  
2027 0  
2028 0  
2029 0  
2030 0  
2031-2067 350  
Secured 0  
Total principal maturities 350  
Total carrying amount 173  
Debt issuance costs $ 0  
v3.26.1
Long-term Debt - Narrative (Details) - Revolver - OMFC
$ in Billions
 3 Months Ended
Mar. 31, 2026
USD ($)
Debt Instrument [Line Items]  
Total borrowing capacity $ 1.1
Debt instrument, term 5 years
v3.26.1
Variable Interest Entities - Schedule of Carrying Amount of Consolidated VIEs (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Variable Interest Entity [Line Items]        
Cash and cash equivalents $ 834 $ 914 $ 627  
Net finance receivables 24,447 24,833    
Allowance for finance receivable losses 2,819 2,865 2,688 $ 2,705
Restricted cash and restricted cash equivalents 728 699 $ 736  
Other assets 1,230 1,252    
Long-term debt 22,396 22,694    
Consolidated VIEs        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 5 5    
Net finance receivables 13,526 13,418    
Allowance for finance receivable losses 1,536 1,558    
Restricted cash and restricted cash equivalents 717 690    
Other assets 42 41    
Long-term debt 11,586 11,464    
Other liabilities $ 29 $ 30    
v3.26.1
Variable Interest Entities - Consolidated VIEs (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Variable Interest Entity [Line Items]    
Interest expense $ 322 $ 312
Consolidated VIEs    
Variable Interest Entity [Line Items]    
Interest expense $ 146 $ 159
v3.26.1
Variable Interest Entities - Securitized Borrowings (Details) - Securitizations
 3 Months Ended
Mar. 31, 2026
Minimum  
Debt Instrument [Line Items]  
Debt instrument, term 2 years
Maximum  
Debt Instrument [Line Items]  
Debt instrument, term 7 years
v3.26.1
Variable Interest Entities - Credit Card Revolving VFN Facilities (Details) - Consolidated VIEs
$ in Millions
 3 Months Ended
Mar. 31, 2026
USD ($)
facility
Debt Instrument [Line Items]  
Number of revolving credit card VFN facilities | facility 2
Revolving Credit Card VFN Facility  
Debt Instrument [Line Items]  
Total borrowing capacity | $ $ 500
Debt instrument, term 4 years
v3.26.1
Variable Interest Entities - Private Secured Term Funding (Details)
$ in Millions
Mar. 31, 2026
USD ($)
Consolidated VIEs | Private Secured Term Funding  
Debt Instrument [Line Items]  
Maximum borrowing capacity $ 350
v3.26.1
Variable Interest Entities - Revolving Conduit Facilities (Details) - Consolidated VIEs - Revolving Conduit Facilities
$ in Billions
 3 Months Ended
Mar. 31, 2026
USD ($)
facility
Line of Credit Facility [Line Items]  
Number of conduit facilities | facility 17
Total borrowing capacity | $ $ 5.9
Debt instrument, term 9 years
v3.26.1
Insurance - Schedule of Changes in the Reserve for Unpaid Claims and Loss Adjustment Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Liability for unpaid claims and claims adjustment expense        
Balance at beginning of period $ 98 $ 102    
Less reinsurance recoverables (3) (2) $ (3) $ (3)
Net balance at beginning of period 95 99    
Additions for losses and loss adjustment expenses incurred to:        
Current year 53 52    
Prior years (2) (6)    
Total 51 46    
Reductions for losses and loss adjustment expenses paid related to:        
Current year (17) (17)    
Prior years (34) (32)    
Total (51) (49)    
Net balance at end of period 95 96    
Plus reinsurance recoverables 3 2 $ 3 $ 3
Balance at end of period $ 98 $ 98    
v3.26.1
Insurance - Schedule of Present Value of Expected Net Premium And Future Policy Benefits (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Term and Whole Life        
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]        
Balance at beginning of period $ 138 $ 177    
Effect of cumulative changes in discount rate assumptions (beginning of period) (1) (1) $ (3) $ (2)
Beginning balance at original discount rate 135 175    
Effect of actual variances from expected experience     (1) (3)
Adjusted balance at beginning of period     134 172
Interest accretion 2 2    
Net premiums collected (6) (6)    
Ending balance at original discount rate 130 168    
Effect of changes in discount rate assumptions 1 1 3 2
Balance at ending of period 131 169    
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]        
Balance at beginning of period 329 378    
Effect of changes in discount rate assumptions (4) (3) (9) (5)
Beginning balance at original discount rate 320 373    
Effect of actual variances from expected experience     (2) (2)
Adjusted balance at beginning of period     318 371
Net issuances 1 1    
Interest accretion 4 5    
Benefit payments (10) (13)    
Ending balance at original discount rate 313 364    
Effect of changes in discount rate assumptions 4 3 9 5
Balance at ending of period 317 367    
Accidental Death and Disability Protection        
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]        
Balance at beginning of period 28 33    
Effect of cumulative changes in discount rate assumptions (beginning of period) 0 1 0 0
Beginning balance at original discount rate 28 33    
Effect of actual variances from expected experience     (2) 0
Adjusted balance at beginning of period     26 33
Interest accretion 0 0    
Net premiums collected (1) (1)    
Ending balance at original discount rate 25 32    
Effect of changes in discount rate assumptions 0 (1) 0 0
Balance at ending of period 25 31    
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]        
Balance at beginning of period 90 96    
Effect of changes in discount rate assumptions 1 2 1 2
Beginning balance at original discount rate 91 98    
Effect of actual variances from expected experience     (4) (1)
Adjusted balance at beginning of period     87 97
Net issuances 0 0    
Interest accretion 1 1    
Benefit payments (2) (3)    
Ending balance at original discount rate 86 95    
Effect of changes in discount rate assumptions (1) (2) $ (1) $ (2)
Balance at ending of period $ 85 $ 93    
v3.26.1
Insurance - Schedule of Net Liability for Future Policy Benefits (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Mar. 31, 2025
Term and Whole Life    
Liability for Future Policy Benefit, Activity [Line Items]    
Net liability for future policy benefits $ 186 $ 198
Deferred profit liability 12 11
Total net liability for future policy benefits 198 209
Accidental Death and Disability Protection    
Liability for Future Policy Benefit, Activity [Line Items]    
Net liability for future policy benefits 60 62
Deferred profit liability 43 47
Total net liability for future policy benefits $ 103 $ 109
v3.26.1
Insurance - Narrative (Details)
Mar. 31, 2026
Mar. 31, 2025
Insurance [Abstract]    
Weighted-average duration of the liability for future policy benefits 7 years 8 years
v3.26.1
Insurance - Schedule of Reconciliation of Net Liability for Future Policy Benefits To the Consolidated Statements of Financial Position (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Liability for Future Policy Benefit, Activity [Line Items]      
Total insurance claims and policyholder liabilities $ 566 $ 576 $ 567
Term and Whole Life      
Liability for Future Policy Benefit, Activity [Line Items]      
Total net liability for future policy benefits 198   209
Accidental Death and Disability Protection      
Liability for Future Policy Benefit, Activity [Line Items]      
Total net liability for future policy benefits 103   109
Other      
Liability for Future Policy Benefit, Activity [Line Items]      
Other $ 265   $ 249
v3.26.1
Insurance - Schedule of Undiscounted and Discounted Expected Gross Premiums And Expected Future Benefits (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Mar. 31, 2025
Term and Whole Life    
Expected future gross premiums:    
Undiscounted $ 273 $ 352
Discounted 206 254
Expected future benefit payments:    
Undiscounted 429 514
Discounted 317 367
Accidental Death and Disability Protection    
Expected future gross premiums:    
Undiscounted 96 119
Discounted 69 85
Expected future benefit payments:    
Undiscounted 124 140
Discounted $ 85 $ 93
v3.26.1
Insurance - Schedule of Consolidated Statements of Operations (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Term and Whole Life    
Liability for Future Policy Benefit, Activity [Line Items]    
Gross premiums or assessments $ 11 $ 12
Interest accretion 2 3
Accidental Death and Disability Protection    
Liability for Future Policy Benefit, Activity [Line Items]    
Gross premiums or assessments 3 4
Interest accretion $ 1 $ 1
v3.26.1
Insurance - Schedule of Actuarial Assumptions (Details)
Mar. 31, 2026
Mar. 31, 2025
Term and Whole Life | Measurement Input, Mortality Rate, Expected    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0041 0.0039
Term and Whole Life | Measurement Input, Mortality Rate, Actual    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0037 0.0041
Term and Whole Life | Measurement Input, Lapses, Expected    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0385 0.0379
Term and Whole Life | Measurement Input, Lapses, Actual    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0416 0.0300
Accidental Death and Disability Protection | Measurement Input, Mortality Rate, Expected    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0002 0.0001
Accidental Death and Disability Protection | Measurement Input, Mortality Rate, Actual    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0001 0.0001
Accidental Death and Disability Protection | Measurement Input, Lapses, Expected    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0160 0.0171
Accidental Death and Disability Protection | Measurement Input, Lapses, Actual    
Market Risk Benefit [Line Items]    
Market risk benefit, measurement input 0.0393 0.0238
v3.26.1
Insurance - Schedule of Weighted-Average Interest Rates for the Liability of Future Policy Benefits (Details)
Mar. 31, 2026
Mar. 31, 2025
Term and Whole Life    
Additional Liability, Long-Duration Insurance [Line Items]    
Interest accretion rate 5.28% 5.29%
Current discount rate 5.40% 5.40%
Accidental Death and Disability Protection    
Additional Liability, Long-Duration Insurance [Line Items]    
Interest accretion rate 4.85% 4.86%
Current discount rate 5.58% 5.49%
v3.26.1
Capital Stock and Earnings Per Share (OMH Only) - Narrative (Details)
 3 Months Ended
Mar. 31, 2026
class
OMH  
Class of Stock [Line Items]  
Number of classes of authorized stock 2
OMFC  
Class of Stock [Line Items]  
Number of classes of authorized stock 2
v3.26.1
Capital Stock and Earnings Per Share (OMH Only) - Schedule of Changes in Shares Issued and Outstanding (Details) - shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance (in shares) 117,196,792 119,360,509
Common stock issued (in shares) 312,854 223,914
Common stock repurchased (in shares) (1,901,698) (323,176)
Treasury stock issued (in shares) 19,313 20,313
Ending balance (in shares) 115,627,261 119,281,560
v3.26.1
Capital Stock and Earnings Per Share (OMH Only) - Schedule of Computation of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Numerator (basic and diluted):    
Net income $ 226 $ 213
Denominator:    
Weighted average number of shares outstanding (basic) (in shares) 116,724,709 119,399,008
Effect of dilutive securities (in shares) 547,895 570,705
Weighted average number of shares outstanding (diluted) (in shares) 117,272,604 119,969,713
Earnings per share:    
Basic (in dollars per share) $ 1.93 $ 1.79
Diluted (in dollars per share) $ 1.93 $ 1.78
Restricted Stock Units    
Earnings per share:    
Shares excluded in the diluted earnings per share calculation (in shares) 494,273 777,055
v3.26.1
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance $ 3,401 $ 3,191
Other comprehensive income, net of tax, before reclassification adjustments (12) 16
Ending balance 3,377 3,280
Unrealized Gains (Losses) Available-for-Sale Securities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (41) (81)
Other comprehensive income, net of tax, before reclassification adjustments (12) 16
Ending balance (53) (65)
Retirement Plan Liabilities Adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (2) (3)
Other comprehensive income, net of tax, before reclassification adjustments 0 0
Ending balance (2) (3)
Foreign Currency Translation Adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (7) (13)
Other comprehensive income, net of tax, before reclassification adjustments (1) 0
Ending balance (8) (13)
Changes in Discount Rate for Insurance Claims and Policyholder Liabilities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (3) (1)
Other comprehensive income, net of tax, before reclassification adjustments 2 1
Ending balance (1) 0
Other    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance 12 17
Other comprehensive income, net of tax, before reclassification adjustments (1) (1)
Ending balance 11 16
Accumulated Other Comprehensive Income (Loss)    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (41) (81)
Ending balance $ (53) $ (65)
v3.26.1
Income Taxes (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Income Tax Disclosure [Abstract]    
Net deferred tax asset $ 438 $ 464
Unrecognized tax benefits $ 17 $ 14
v3.26.1
Segment Information - Narrative (Details)
 3 Months Ended
Mar. 31, 2026
segment
Segment Reporting [Abstract]  
Number of reportable segments 1
v3.26.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Segment Reporting Information [Line Items]      
Interest income $ 1,387 $ 1,308  
Interest expense 322 312  
Provision for finance receivable losses 465 456  
Net interest income after provision for finance receivable losses 600 540  
Other revenues 197 188  
Salaries and benefits 240 218  
Other operating expenses 209 186  
Insurance policy benefits and claims 52 49  
Income before income taxes 296 275  
Assets 27,018 26,029 $ 27,388
Consumer and Insurance | Consumer and Insurance      
Segment Reporting Information [Line Items]      
Interest income 1,383 1,301  
Interest expense 322 311  
Provision for finance receivable losses 465 456  
Net interest income after provision for finance receivable losses 596 534  
Other revenues 195 186  
Salaries and benefits 239 217  
Other operating expenses 207 184  
Insurance policy benefits and claims 52 49  
Income before income taxes 293 270  
Assets 25,869 24,889  
Other      
Segment Reporting Information [Line Items]      
Interest income 1 1  
Interest expense 0 0  
Provision for finance receivable losses 0 0  
Net interest income after provision for finance receivable losses 1 1  
Other revenues 2 2  
Salaries and benefits 1 1  
Other operating expenses 2 1  
Insurance policy benefits and claims 0 0  
Income before income taxes 0 1  
Assets 6 11  
Segment to GAAP Adjustment      
Segment Reporting Information [Line Items]      
Interest income 3 6  
Interest expense 0 1  
Provision for finance receivable losses 0 0  
Net interest income after provision for finance receivable losses 3 5  
Other revenues 0 0  
Salaries and benefits 0 0  
Other operating expenses 0 1  
Insurance policy benefits and claims 0 0  
Income before income taxes 3 4  
Assets $ 1,143 $ 1,129  
v3.26.1
Fair Value Measurements - Schedule of Fair Value & Carrying Value Hierarchy Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Assets      
Restricted cash and restricted cash equivalents $ 728 $ 699 $ 736
Total Fair Value      
Assets      
Cash and cash equivalents 834 914  
Investment securities 1,614 1,590  
Net finance receivables, less allowance for finance receivable losses 24,036 24,440  
Restricted cash and restricted cash equivalents 728 699  
Other assets 31 31  
Liabilities      
Long-term debt 22,369 23,204  
Total Carrying Value      
Assets      
Cash and cash equivalents 834 914  
Investment securities 1,614 1,590  
Net finance receivables, less allowance for finance receivable losses 21,628 21,968  
Restricted cash and restricted cash equivalents 728 699  
Other assets 17 18  
Liabilities      
Long-term debt 22,396 22,694  
Level 1      
Assets      
Cash and cash equivalents 819 860  
Investment securities 59 57  
Net finance receivables, less allowance for finance receivable losses 0 0  
Restricted cash and restricted cash equivalents 728 699  
Other assets 0 0  
Liabilities      
Long-term debt 0 0  
Level 2      
Assets      
Cash and cash equivalents 15 54  
Investment securities 1,551 1,530  
Net finance receivables, less allowance for finance receivable losses 0 0  
Restricted cash and restricted cash equivalents 0 0  
Other assets 0 0  
Liabilities      
Long-term debt 22,369 23,204  
Level 3      
Assets      
Cash and cash equivalents 0 0  
Investment securities 4 3  
Net finance receivables, less allowance for finance receivable losses 24,036 24,440  
Restricted cash and restricted cash equivalents 0 0  
Other assets 31 31  
Liabilities      
Long-term debt $ 0 $ 0  
v3.26.1
Fair Value Measurements - Schedule of Assets at Fair Value Recurring Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Investment securities:    
Available-for-sale securities $ 1,555 $ 1,532
Other securities 59 58
U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 13 13
Obligations of states, municipalities, and political subdivisions    
Investment securities:    
Available-for-sale securities 55 56
Commercial paper    
Investment securities:    
Available-for-sale securities 13 0
Non-U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 148 157
Corporate debt    
Investment securities:    
Available-for-sale securities 1,047 1,030
RMBS    
Investment securities:    
Available-for-sale securities 191 190
CMBS    
Investment securities:    
Available-for-sale securities 18 22
CDO/ABS    
Investment securities:    
Available-for-sale securities 70 64
Level 1    
Investment securities:    
Total investment securities 59 57
Level 2    
Investment securities:    
Total investment securities 1,551 1,530
Level 3    
Investment securities:    
Total investment securities 4 3
Fair Value, Measurements, Recurring    
Assets    
Cash equivalents in mutual funds 68 48
Cash equivalents in securities 15 53
Investment securities:    
Available-for-sale securities 1,555 1,532
Other securities 59 58
Total investment securities 1,614 1,590
Restricted cash equivalents in mutual funds 612 620
Total 2,309 2,311
Fair Value, Measurements, Recurring | Total bonds    
Investment securities:    
Other securities 4 6
Fair Value, Measurements, Recurring | U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 13 13
Fair Value, Measurements, Recurring | Obligations of states, municipalities, and political subdivisions    
Investment securities:    
Available-for-sale securities 55 56
Fair Value, Measurements, Recurring | Commercial paper    
Investment securities:    
Available-for-sale securities 13  
Fair Value, Measurements, Recurring | Non-U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 148 157
Fair Value, Measurements, Recurring | Corporate debt    
Investment securities:    
Available-for-sale securities 1,047 1,030
Other securities 3 3
Fair Value, Measurements, Recurring | RMBS    
Investment securities:    
Available-for-sale securities 191 190
Fair Value, Measurements, Recurring | CMBS    
Investment securities:    
Available-for-sale securities 18 22
Fair Value, Measurements, Recurring | CDO/ABS    
Investment securities:    
Available-for-sale securities 70 64
Other securities 1 3
Fair Value, Measurements, Recurring | Preferred stock    
Investment securities:    
Other securities 12 12
Fair Value, Measurements, Recurring | Common stock    
Investment securities:    
Other securities 43 40
Fair Value, Measurements, Recurring | Level 1    
Assets    
Cash equivalents in mutual funds 68 48
Cash equivalents in securities 0 0
Investment securities:    
Available-for-sale securities 5 6
Other securities 54 51
Total investment securities 59 57
Restricted cash equivalents in mutual funds 612 620
Total 739 725
Fair Value, Measurements, Recurring | Level 1 | Total bonds    
Investment securities:    
Other securities 0 0
Fair Value, Measurements, Recurring | Level 1 | U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Obligations of states, municipalities, and political subdivisions    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Commercial paper    
Investment securities:    
Available-for-sale securities 0  
Fair Value, Measurements, Recurring | Level 1 | Non-U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Corporate debt    
Investment securities:    
Available-for-sale securities 5 6
Other securities 0 0
Fair Value, Measurements, Recurring | Level 1 | RMBS    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 1 | CMBS    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 1 | CDO/ABS    
Investment securities:    
Available-for-sale securities 0 0
Other securities 0 0
Fair Value, Measurements, Recurring | Level 1 | Preferred stock    
Investment securities:    
Other securities 12 12
Fair Value, Measurements, Recurring | Level 1 | Common stock    
Investment securities:    
Other securities 42 39
Fair Value, Measurements, Recurring | Level 2    
Assets    
Cash equivalents in mutual funds 0 0
Cash equivalents in securities 15 53
Investment securities:    
Available-for-sale securities 1,547 1,524
Other securities 4 6
Total investment securities 1,551 1,530
Restricted cash equivalents in mutual funds 0 0
Total 1,566 1,583
Fair Value, Measurements, Recurring | Level 2 | Total bonds    
Investment securities:    
Other securities 4 6
Fair Value, Measurements, Recurring | Level 2 | U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 13 13
Fair Value, Measurements, Recurring | Level 2 | Obligations of states, municipalities, and political subdivisions    
Investment securities:    
Available-for-sale securities 55 56
Fair Value, Measurements, Recurring | Level 2 | Commercial paper    
Investment securities:    
Available-for-sale securities 13  
Fair Value, Measurements, Recurring | Level 2 | Non-U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 148 157
Fair Value, Measurements, Recurring | Level 2 | Corporate debt    
Investment securities:    
Available-for-sale securities 1,039 1,022
Other securities 3 3
Fair Value, Measurements, Recurring | Level 2 | RMBS    
Investment securities:    
Available-for-sale securities 191 190
Fair Value, Measurements, Recurring | Level 2 | CMBS    
Investment securities:    
Available-for-sale securities 18 22
Fair Value, Measurements, Recurring | Level 2 | CDO/ABS    
Investment securities:    
Available-for-sale securities 70 64
Other securities 1 3
Fair Value, Measurements, Recurring | Level 2 | Preferred stock    
Investment securities:    
Other securities 0 0
Fair Value, Measurements, Recurring | Level 2 | Common stock    
Investment securities:    
Other securities 0 0
Fair Value, Measurements, Recurring | Level 3    
Assets    
Cash equivalents in mutual funds 0 0
Cash equivalents in securities 0 0
Investment securities:    
Available-for-sale securities 3 2
Other securities 1 1
Total investment securities 4 3
Restricted cash equivalents in mutual funds 0 0
Total 4 3
Fair Value, Measurements, Recurring | Level 3 | Total bonds    
Investment securities:    
Other securities 0 0
Fair Value, Measurements, Recurring | Level 3 | U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 3 | Obligations of states, municipalities, and political subdivisions    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 3 | Commercial paper    
Investment securities:    
Available-for-sale securities 0  
Fair Value, Measurements, Recurring | Level 3 | Non-U.S. government and government sponsored entities    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 3 | Corporate debt    
Investment securities:    
Available-for-sale securities 3 2
Other securities 0 0
Fair Value, Measurements, Recurring | Level 3 | RMBS    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 3 | CMBS    
Investment securities:    
Available-for-sale securities 0 0
Fair Value, Measurements, Recurring | Level 3 | CDO/ABS    
Investment securities:    
Available-for-sale securities 0 0
Other securities 0 0
Fair Value, Measurements, Recurring | Level 3 | Preferred stock    
Investment securities:    
Other securities 0 0
Fair Value, Measurements, Recurring | Level 3 | Common stock    
Investment securities:    
Other securities $ 1 $ 1